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NOTES
1. All the temperatures are expressed in degree centigrade (0C).
2. Melting points of all the compounds are uncorrected and
have been recorded by open capillary method.
3. Room temperature, wherever mentioned, normally corresponds
to 280 - 33 0C.
4. Silica gel-G was used for preparing the TLC plates using
different solvent systems.
5. Infra red spectra  of all the compounds were scanned on
SHIMADZU-FOURIER TRANSFORM INFRA RED
(FTIR)-8400 Spectrophotometer using KBr disc.
6. PMR Spectra were recorded on BRUKER Spectrophotom-
eter(400 MHz) using TMS as a internal standard and CDCI3,
and DMSO-d6 as solvents.
7. 13C NMR Spectra were recorded on BRUKER Spectropho-
tometer(400 MHz) using CDCI3 and DMSO-d6 as solvents.
8. MASS spectra were recorded on SHIMADZU-GCMS-QC-
2010.
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Synopsis... , “Studies on compounds of therapeutic interest”. 1
A brief summary of the research work to be incorporated in the thesis
entitled “Studies on compounds of therapeutic interest” has been divided
into four parts which can be summarised  as under.
(A) STUDIES ON DERIVATIVES OF 1-SUBSTITUTED PHENYL-3-(m-
PHENOXYPHENYL)-2-PROPEN-1-ONES.
(B) STUDIES ON 2,4,6-TRISUBSTITUTED-3-CYANO PYRIDINES.
(C) STUDIES ON CYCLOHEXENONE DERIVATIVES.
(D) STUDIES ON 1,5-BENZOHETEROZEPINES.
(A) STUDIES ON DERIVATIVES OF 1-SUBSTITUTED PHENYL-3-(m-
PHENOXYPHENYL)-2-PROPEN-1-ONES.
m-Phenoxybenzaldehyde is associated with wide spectrum of biologi-
cal activities like antimicrobial, antiinflammatory, anthelmentic, analgesic, an-
tidepressant, anti-HIV, antitubercular, anticancer, CNS depressant  and anti-
fungal properties. Hence, it is of interest to undertake synthesis of various
derivaties of m-phenoxybenzaldehyde with better biological activities. The syn-
thes is  o f  var ious der ivat ies  o f  m-phenoxybenzaldehyde invo lves
bromochalcones, epoxy  derivatives which are described in the following sec-
tions as under.






    R=Substituted phenyl
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1-Substituted phenyl-3-(m-phenoxy phenyl)-2-propen-1-ones  (Ia-j) have
been synthesized by the condensation of m-phenoxy benzaldehyde with vari-
ous aromatic ketones  in the presence of 40% aqueous sodium hydroxide
solution.







R  =Substituted phenyl
2,3-Dibromo-3-(m-phenoxyphenyl)-1-substituted phenyl propan-1-ones
(IIa-j) have been synthesized by  the addition reaction of  1-substituted phenyl-
3-(m-phenoxy phenyl)-2- propen-1-ones (Ia-j)  with bromine in glacial acetic acid
at ambient  temperature.







  R=Substituted phenyl
3-(m-Phenoxyphenyl)-oxiran-2-yl-substituted phenyl methanones
(IIIa-j) have been prepared by the reaction of 1-substituted phenyl-3-(m-phe-
noxy phenyl)-2-propen-1-ones (Ia-j)  with alkaline hydrogen peroxide in
tetrahydro furan at room temperature.
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(B) STUDIES ON  2,4,6-TRISUBSTITUTED-3-CYANO PYRIDINES.
2,4,6-trisubstituted-3-cyano pyridine derivatives have been reported to
be active in various field such as antitumor, antihypertensive, antiinflamma-
tory,  antimicrobial, analgesic and antiviral. In serach of potent  therapeutic
agents, these valid observations led us to synthesis some new 2,4,6-trisubsti-
tuted-3-cyano pyridines which have been described in the following sections
as under.










(IVa-j) have been prepared by the cyclocondensation of 1-substituted phenyl-
3-(m-phenoxy phenyl)-2-propen-1-ones (Ia-j) with malanonitile  in the alkaline
medium.
Section - II : Preparation and biological evaluation of 2-Butoxy-4-








  R=Substituted phenyl
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2-Butoxy-4-substituted phenyl-6-(m-phenoxyphenyl)-nicotino nitriles
(Va-j) have been prepared by the cyclo condensation of 1-substituted phenyl-
3-(m-phenoxy phenyl)-2-propen-1-ones (Ia-j) with malanonitile in the alkaline
medium.
Section - III :Preparation and biological evaluation of 2-Isopropoxy-4-











(VIa-j) have been prepared by the cyclo condensation of 1-substituted phenyl-
3-(m-phenoxyphenyl)-2-propen-1-ones (Ia-j)  with malanonitile  in the alkaline
medium.
(C) STUDIES ON CYCLOHEXENONE DERIVATIVES.
Cyclohexenone derivatives have been found to be potent drugs in phar-
maceuticals and possess  wide spectrum of  biological activites viz., antifun-
gal, cardiovascular, sedative, antibacterial, antiviral and other pharmacologi-
cal activities. In view of  these facts, it was contemplated to synthesize some
cyclohexenone derivatives which have been described in the following sec-
tions which are as under.
Section - I: Preparation and biological evaluation of Methyl- 4-substi-
tuted phenyl-2-oxo-6-(m-phenoxyphenyl)-cyclohex-3-
ene-1-carboxylates.









1-carboxylates  (VIIa-j) have been prepared by the condensation reaction  of  1-
substituted phenyl-3-(m-phenoxy phenyl)-2-propen-1-ones (Ia-j) with  methyl ac-
etoacetate in the presence of basic catalyst.











carboxylates  (VIIIa-j) have been prepared by the condensation reaction  of  1-
substituted phenyl-3-(m-phenoxy phenyl)-2-propen-1-ones (Ia-j) with  ethyl ac-
etoacetate in the presence of basic catalyst.
Section- III:Preparation and biological evaluation of 6-acetyl-3-substi-
tuted phenyl-5-(m-phenoxy phenyl)-cyclohex-2-ene-1-ones.








(IXa-j)  have been prepared by the condensation reaction  of 1-substituted phe-
nyl-3-(m-phenoxy phenyl)-2-propen-1-ones (Ia-j) with  acetyl acetone in the pres-
ence of basic catalyst.
(D) STUDIES ON 1,5-BENZOHETEROZEPINES.
1,5-Benzoheterozepines are of current  interest  because they possess
broad spectrum  pharmacological activites which are reflected  by  their use
as antitubercular, anticonvulsant, antifungal, CNS depressant and sedative
agent. Prompted by these facts, new diazepines, thiazepines and oxazepines
have been synthesized which are described in the following sections.
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(Xa-j) have been prepared by the cyclo condensation  of 1-substituted phenyl-
3-(m-phenoxy phenyl)-2- propen-1-ones (Ia-j)  with o-phenylene diamine in the
presence of  acidic medium.









4-Subs t i tu tedpheny l -2 - (m-Phenoxypheny l ) -2 ,5 -d ihydro -1 ,5 -
benzothiazepines (XIa-j) have been prepared by the condensation  of 1-sub-
stituted phenyl-3-(m-phenoxy phenyl)-2-propen-1-ones (Ia-j) with o- amino
thiophenol in the presence of  acidic medium.








 R = Substituted phenyl
4-Substituted phenyl-2-(m-phenoxy phenyl)-2,5-dihydro-1,5-benzoxazepines
(XIIa-j) have been prepared by the condensation  of 1-substituted phenyl-3-
Synopsis... , “Studies on compounds of therapeutic interest”. 8
(m-phenoxy phenyl)-2-propen-1-ones (Ia-j) with o-amino phenol in the pres-
ence of  acidic medium.
PURIFICATION AND STRUCTURAL CHARACTRISATION
The purity of all compounds (Ia-j to XIIa-j) have been routinely checked
by thin layer chromatography using two different solvent systems(Rf1 & Rf2).
The constitution of newly synthesized compounds (Ia-j to XIIa-j) have been
delineated by  elemental analysis, FT-IR, 1H NMR and Mass spectoscopy.
ANTIMICROBIAL ASSAY
The purified organic compounds (Ia-j to XIIa-j) have been screened for
their in vitro  therapeutic assay  like antibacterial activity  towards Gram
possitive and Gram negative bacterial strains and antifungal activity
towards fungal strains at different concentrations (Minimum Inhibitory
Concentration). The biological activities of synthesized compounds (Ia-j to
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STUDIES ON COMPOUNDS OF THERAPEUTIC INTEREST
(A) Drug
The word drug is derived from the French word “drogue” which means
‘a dry herb’. It is the single active chemical entity present in a medicine that
is used for diagnosis, prevention, treatment / cure of a disease. This dis-
ease oriented definition of drug does not include contraceptives or use of
drugs for improvement of health. According to “WHO” a drug may be defined
as “Any  substance or product which is used or intended to be used for modi-
fying or exploring physiological system as pathological status for the benefit
of the recipient”.
(B) Pharmacology
Pharmacology is the science of drugs. In a broad sense, it deals with
interaction of exogenously administered chemical molecules (drugs) with
living system. It encompasses all aspects of knowledge about drugs, but most
importantly those that are relevant to effective and safe use for medicinal
purposes. For thousands of years most drugs were crude natural products of
unknown composition and limited efficiency. Only the over effects of these
substances on the body were rather imprecisely known, but how the same were
produced was entirely unknown. Over the past 100 years or so, drugs have
been purified, chemically characterized and a vast variety of highly potent and
selective new drugs has been developed. The two main divisions of
pharmacology are pharmacodynamics and pharmacokinetics.
(a) Pharmacodynamics : It is derived from the Greek word “dynamic”
means power. What the drugs does to the body? This includes physiologi-
cal and biochemical  ef fects of  drugs and thei r  mechanism of  act ion
at macromolecular / sub cellular organ systems.
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(b) Pharmacokinetics : It is derived from the Greek word ‘Kinesis’
means movement. What the body does to the drug ? This refers to move-
ments of the drug in and alternation of the drug by the body; includes ab-
sorption, d ist r ibut ion,  b inding /  local izat ion /  s torage,  b iotransforma-
t ion and excretion of the drug.
Some other important aspects of pharmacology are given as under
:
* Pharmacotherapeut ics  :  I t  i s  t he  app l i ca t i on  o f  pha rmaco-
dynamic information together with knowledge of the disease for its
prevention, mitigation or cure.
* Clinical  Pharmacology :  I t  is  the sc ient i f ic  s tudy of  drug in
man. I t  inc ludes pharmacodynamic and pharmacokinet ic  inves
tigation in healthy volunteers and in patients; evaluation of efficiency
and safety  o f  d rugs  and  compara t i ve  t r i a l s  w i th  o the r fo rms
o f  t rea tmen ts ;  surveillance of patterns of drug uses, adverse
effects, etc.
* Chemotherapy : It is the treatment of systemic infection / malignancy
wi th speci f ic  drugs that  have se lect ive tox ic i ty  for  the in fect
ing organism / malignant cell with less effect on the host cells.
?  Drugs in general, can thus be divided into :
* Pharmacodynamic agents :  These are chemical substances
designed to have pharmacodynamic effect in the recipient.
* Chemotherapeutic agents : These are chemical substances designed
for the treatment of infectious diseases or by the proliferation of malignant cells.
(c) Essential Drug Concept: The ‘WHO’ has defined Essential Drugs
as “those that satisfy the healthcare needs of majority of the population; they
should therefore be available at all times in adequate amounts and in
appropriate dosage form”.
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I t  has been real ized that  only a handful  of  drugs out of  the
multitude available can meet the health needs of majority of the people in any
country, and that may be well tested and cheaper drugs are equally (or more)
efficient and safe as their newer more expensive congeners. For optimum
utilization of resources, governments (specially in developing countries) should
concentrate on these drugs by identifying them as Essential Drugs. The “WHO”
has laid down criteria guide selection of an essential drug :
(I) Adequate data on its efficiency and safety should be available from
          clinical studies.
(II) It should be available in a form in which quality, including bioavailability and
stability on storage can be assured.
(III) Its choice should depend upon pattern of prevalent diseases; avail
ability  o f  fac i l i t ies  and t ra ined personne l ;  f inanc ia l  resources;
genet ic ,  demographic and environmental factors.
(IV) In case of two or more similar drugs, choice should be made on the
basis of their relative efficiency, safety, quality, price, availabil ity
and cost benefit ratio should be a major consideration.
(V) Choice may also be influenced by comparative pharmacokinetic proper
ties and local facilities for manufacture and storage.
(VI) Most essential drug should be single compound. Fixed ratio combina
tion products should be included only when dosage of each ingredient
meets the requirements of a defined population group, and when the
combination has a proven advantage.
(VII) Selection of essential drug should be a continuous process which should
take into account the changing priorities for public health action, epide-
miological condition as well as availability of better drugs/ formulations
and progress in pharmacological knowledge.
(C)  Drug Development
Many natural products by trial and error, came into practise for combat-
ing human ailments existent during early human observation. With the advent
of    modern scientific approach, various plant medicines came under
chemical scrutiny, ultimately leading to the isolation of active principles since
early.
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Such compounds either in extract form or in pure form became a part of
pharmacopoeias. For instance, though the Chinese drug, Mauhang was in use
for over 5000 years for the treatment of various types of fever and respiratory
ailments, its active principle, Ephidrine was isolated in 1887. In 1925 chemi-
cal investigations followed by pharmacological evaluation led this compound
into the modern medicine. Similarly during this period, urea stibamine was
introduced as the first drug in 1920 for the treatment of Kala-azar. In 1930, De
Rauwolfia preparation were first employed for sedative and hypotensive prop-
erties.
A drug is a substance having abnormal effect on certain body functions
eg. Strychnine stimulates the action of heart and aspirin retards its action.
Since both of them effects abnormally, the two substances are known as drugs.
Chemical    sciences contributed extensively new discoveries leading to use-
ful drugs since after 1930. The modern concept of drug discovery started in
1933 by Gerhand Domagk with his finding of “Prontosil Red”, a compound
responsible for the antibacterial activity. The advent of sulphonamides drew
the attention for the different activities of various chemicals for bacterial and
human cells, this important factor prompted Florey and Chain in 1939 to in-
vestigate penicillin which was discovered ten years earlier by Alexander
Fleming. The spectacular chemotherapeutical properties of penicillin and its
dramatic war-time development for the treatment of wounds made penicillin,
a most commonly used inexpensive drug.
           A large number of important drugs have been introduced during the
period of 1940 to 1980. This period is known as “Golden period” of new drug
discovery. Thus starting from 1933 - the first antibacterial drug prontosil lead-
ing to various  sulpha drugs ; 1940 – penicillin ; 1945 – chloroquine – anti-
malarial ; 1950 – Methyldopa – anti-hypertensive; 1967 – chlorothiazine
-diuretic; 1958 - adrenergic beta blockers coronary vasodilatory; 1960 - semi
synthetic penicillin -antibacterial; 1965 -trimethoprim-antimicrobial;1967-
disodium chromoglycoate - antiallergic; 1972 - cimetidine H2– antagonist;
1975 -verapamil- calciumantagonist and 1981 - captopril - antihypertensive.
There are some specific examples representing new therapeuticagent  eg. Metormine
glipizide-anti diabetic.
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(D) Latest Drug Developments
The current interest in the creation of large, searchable libraries of
organic compounds has captured the imagination of organic chemists and
the drug discovery community. In numerous laboratories the Efforts are focused
on the introduction of chemical diversity, which have been recently reviewed
and pharmacologically interesting compounds have been identified from li-
braries of widely different compositions.
Today, the chief source of agents for the cure, the mitigation or the
prevention of diseases are the organic compounds, natural or synthetic, to-
gether with so-called organometallics. Such agents have their origin in a num-
ber of ways (a) from naturally occurring materials - of both plant and animal
origin, and (b) from the isolation of organic compounds synthesized in labora-
tory whose structures are closely related to those of naturally occurring com-
pounds for eg. atropine, steroids, morphine, cocaine etc. that have been
known to possess useful medicinal properties.
The process of drug design is extensively driven by the instinct  and
experience of pharmaceutical research scientists. It is often instructive to at-
tempt to “capture” these experiences by analyzing the historical record that
are successful drug design projects of the past. From this analysis, the infer-
ences are drawn  which play an important role in shaping our  current and
future projects. Towards this region, we would like to analyse the structures of
a large number of drugs - the ultimate product of a successful drug design
effort. Our goal for this is to  begin to deconvolute this information in order to
apply it to design of new drugs.
Different kinds of drugs are developed for different types of diseases
viz. which can be defined with their names of the modern drugs are as under.
(a) Anticancer drugs
The drugs, which stops the abnormal growth of cell tissues in human
body, are termed as anticancer drug. Vinblastin and Busulphan are the novel
anticancer drugs.
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(b) Hepatoprotective drugs
Drugs, which gives vitality to liver and protects liver by giving immunity
power against antibodies, are termed as Hepatoprotective drug.
(c) Antimalarial drugs
Drugs, which kills the plasmodium causing malaria are called antima-
larial drug. Combination of Sulphamethoxazole with Pyrimethamine is a
novel antimalarial drug.
(d)      Drug for meningitis
Drugs, which cures the inflammation of meningitis, are termed as
meningitis drugs Cifalexin is a novel meningitis drug.
(e)      Drug for typhoid
Drugs, which kills the bacteria of Salmonella typhi causing typhoid are
known as typhoid drugs. A novel drug for typhoid is Ciprofloxacin.
(f)       Antidiabetic drugs
Drugs, which converts the excess glucose of blood into glycogen are
termed as antidiabetic drugs. Novel antidiabetic drugs are Metformin,
Glipizide and Gliclazide.
(g) Antitubercular drugs
Drugs, which kills the bacteria of mycobacterium tuberculosis and thus
cures lesions of pleural cavity. A novel antitubercular drug is Ethambutol.
(h) Antiasthamatic drugs
             Drugs, which prevents the attack of asthama and gives relax respira-
tion are called antiasthamatic drugs. Novel antiasthamatic drugs are
Ethophylline, Theophylline and Asmon.
(i) Antihypertensive drugs
            Drugs, which normalizes the blood pressure by dilating blood vessels
are called antihypertensive drugs. Novel antihypertensive drugs are
Atenolol,  Amlodipine and Nifedipine.
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(j)        Anti-AIDS drugs
          Drugs, which kills the viruses of AIDS i.e., HIV-1 and HIV-2 are called
anti-AIDS drugs. Novel drugs are Zidovudine, Acyclovir and Didanosine.
(k) Antacid drugs
           Drugs, which neutralize the acid in stomach and stops excessive
secretion of acid, are called antacid drugs. Novel antacid drugs are
Omeprazole and Lansoprazole.
(l)      Non steroidal antiinflammatory drugs (NSAID)
Drugs, which gives relief from fever, pain and inflammation are called
NSAID. Novel NSAID are Pyroxicam, Meloxicam and Nimesulide.
Different kind of drugs generally used are designed as anaesthetic,
ant i tuberculostat ic,  ant ihypertensive, ant iconvulsant,  anthelmint ic,
antiinflammatory, sedative and hypnotics which prompted us to synthesise
drugs having pyrazolo[3,4-d]pyrimidines, quinazolines and pyrazoles moi-
eties as a better therapeutic activity.
? Aims and objectives of the present investigation are
(a) To generate  severa l  b io log ica l ly  ac t ive  moie t ies  such as
pyrazolo[3,4-d]pyrimidines, quinazolines and pyrazoles.
(b) To characterize these products for their structural assignment using
various spectroscopic techniques like IR, PMR and Mass spectroscopy.
(c) To screen these new derivatives for their antimicrobial activity using
different s t ra ins  o f  bacter ia  and fung i  and to  compare ant imicrob ia l
act iv i ty  with
different known drugs at different concentrations for their MIC values.
In view of these facts, the research work presented in thesis are as
follows.
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(A) STUDIES ON DERIVATIVES OF 1-SUBSTITUTED PHENYL-3- (m-
PHENOXYPHENYL)-2-PROPEN-1-ONES.
(B) STUDIES ON  2,4,6-TRISUBSTITUTED-3-CYANO PYRIDINES.
(C) STUDIES ON CYCLOHEXENONE DERIVATIVES.
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PART - I
STUDIES ON DERIVATIVES OF 1-SUBSTITUTED-3-(m-PHENOXY
PHENYL)-2-PROPEN-1-ONES.
INTRODUCTION
The chalcones are also known as 1,3-disubstituted-2-propen-1-ones.
The other alternative names given to the chalcone are phenyl styryl ketones,
β-phenyl acryl phenones, α-phenyl-β-benzo ethylene, benzyl acetophenones
and α-oxo-α,β-diphenyl-α-propylene.
1,3-Disubstituted-2-propen-1-ones are chemically defined by their
possession of a structure in which two aromatic /alkyl aryl/alkyl heterocyclic
and aryl heterocyclic groups are linked by reactive α,β unsaturated ketonic or
1,2,3 (α,β,γ)-unsaturated keto ethylenic group having aliphatic three carbon










   R = R’= Diaryl / alkyl aryl / alkyl heterocyclic / aryl
      heterocyclic groups
The chemistry of chalcones have generated intensive scientific
studies throughout the world, due to their wide biological and industrial
applications. Chalcones are coloured compounds because of the presence of
the chromophore and auxochromes. They are known as benzalacetophenones
or benzylidene acetophenones. Kostanecki and Tambor1 gave the name
Chalcone.
SYNTHETIC ASPECT
 The preparation of 1,3-disubstituted-2-propen-1-ones involves the
condensation of substituted phenyl ethanone/heterocyclic ethanone with
substituted benzaldehyde or heterocyclic aldehydes in presence of either base
or acid.18   The above said reaction is known as Claisen-Schmidt reaction.
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Several condensing agents are used such as alkali of different
strength2,11 anhydrous aluminium chloride,5  boron trifluoride,6  aqueous
solution of borax,7 amino acids,8 phosphorous oxychloride,12  piperidine,13
hydrochloric  acid,10,14 perchloric acid15, etc. Different methods of synthesis
of 1,3-disubstituted-2-propen-1-ones can be quoted as below.
(I) By Fridel Craft cinnamoylation.3
(II) By Nencki reaction with cinnamic acid on aromatic compounds.4
(III) By Fries rearrangement of aryl cinnamates.9
(IV) By diazo coupling of phenyl diazonium chloride with benzoyl acrylic
acid.16
MECHANISM :
Formation of 1,3-disubstituted-2-propen-1-ones proceeds through
Claisen-Schmidt type condensation and the process is catalyzed by the






































The Aldol type intermediate (a) product formed readily undergoes
dehydration even under mild condition.
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REACTIVITY OF 1,3-DISUBSTITUTED-2-PROPEN-1-ONES :
The 1,3-disubstituted-2-propen-1-ones have been found to be useful for
the synthesis of variety of heterocyclic compounds are as under.
(a) 1,3-Disubstituted-2-propen-1-ones oncondensation with ethyl cyano
acetate affordsCyanopyridone.19
(b) 1,3-Disubstituted-2-propen-1-ones on reaction with 2-aminopyridine
in glacial acetic acid affords pyridopyrimidines.20
(c) 1,3-Disubstituted-2-propen-1-ones on treatment with guanidine
hydrochloride in presence of alkali affords 2-amino pyrimidines.21
(d) 1,3-Disubstituted-2-propen-1-ones on condensation with malononitrile
and ammonium acetate yields 2-amino-3-cyano pyridines.22
(e) 1,3-disubstituted-2-propen-1-ones on condensat ion  with hydroxyl
amine hydrochloride and sodium acetate affords Isoxazoles.23
(f) 1,3-Disubstituted-2-propene-1-ones with 2-amino thiophenol in acetic
acid produces 1,5-thiazepines.24
(g) 1,3-Disubstituted-2-propen-1-ones on condensat ion  with hydrazine
hydrate and acetic acid affords Pyrazo l ines.25
(h) 1,3-Disubstituted-2-propen-1-ones on condensat ion with H2O2 in
basic media affords Oxirane.26
(i) 1,3-Disubstituted-2-propen-1-ones react with P2S5 to yield 2-iso-
thiazolidines.27
(j) 1,3-Disubstituted-2-propen-1-ones with monoethanolamine in ethanol
gives 1,4-oxazipines.28
(k) 1,3-Disubstituted-2-propen-1-ones on reac t ion  w i th  barb i tu r ic
ac id  gave  barb i tone29 derivatives.
(l) 1,3-Disubstituted-2-propen-1-ones on  t r ea tmen t  w i t h  u rea  i n
p r e s e n c e  o f  a l k a l i a f f o r d s  2 - oxopyrimidines.30
(m) 1,3-Disubstituted-2-propen-1-ones react with sodium nitrile in presence
of glacial acetic acid in ethanol to produce 2-1H-pyrimidines.31
(n) 1,3-Disubstituted-2-propen-1-ones on condensation with
malononitr i le in pyridine forms 2-amino-3-cyano-pyrans.32
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(o) 1,3-Disubstituted-2-propen-1-ones give imine derivatives with amine
in presence of sulfuric acid as catalyst.33
(p) 1,3-Disubstituted-2-propen-1-ones on reaction with semicarbazide
hydrochloride in ethanol affords1-carboxamide pyrazolines.34
MEDICINAL INTEREST
1,3-Disubstituted-2-propen-1-ones and its derivatives are widely used
in pharmaceutical field. Considerable interest has been shown in the chemistry
of 1,3-disubstituted-2-propen-1-ones due to their wide spectrum of therapeutic
activities which are listed as under.
1.   Anthelmintics42,35
2.   Cardiovascular36
3.   Antispasmodic37
5.   Antiulcer38,39
6.   Antiinflammatory48,40
7.   Fungicidal41,50,51
8.   Antiallergic43




14. Antiviral and Antitubercular54
15.  Anti-HIV55
N. Liming et. al.,56 have synthesized 1,3-disubstituted-2-propen-1-ones
and screened for their antiinflammatory and cardiovascular activity. K. Srinivas
et. al.,57 have synthesized 1,3-disubstituted-2-propen-1-ones as a antitumor
agent. Ko Horng-Huey et. al.,58 have reported 1,3-disubstituted-2-propene-
1-ones as antiinflammatory agent. N. Kazuhiko et. al.,59 have synthesized 1,3-
disubstituted-2-propen-1-ones as carcinogen inhibitors. Antitubercular activity
of 1,3-disubstituted-2-propen-1-ones derivatives have been reported by L. Yuh-
Meei et. al.,60  B. P. Das et. al.,61 have found that 1,3-disubstituted-2-propen-
1-ones possesses larvicidal properties. K. Min-Young et. al.,62 have
synthesized 1,3-disubstituted-2-propen-1-ones and tested for their matrix
metallo proteinase inhibitor activity.
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L. Mei et. al.,63 have prepared antimalarial 1,3-disubstituted-2-propen-
1-ones. O. Veronika et. al.,64 have synthesized 1,3-disubstituted-2-propen-1-
ones and screened as cardiovascular agents. Moreover, it has been found
that 1,3-disubstituted-2-propen-1-ones  possess nitric oxide inhibitor,65,66
anti HIV67,68 and antiproliferative69,70 activities.  H. H. Ko et. al.,71 have
prepared some new 1,3-disubstituted-2-propen-1-ones for potent inhibition
of platelet aggregation.  Z. H. L. et. al.,72  have reported some 1,3-disubstituted-
2-propen-1-ones as antiparasitic. G. M. L. et. al.,73 have documented the
synthesis and biological activities of 1,3-disubstituted-2-propen-1-ones as
antiplasmodial. C. X. Xue et. al.,74 have documented 1,3-disubstituted-2-
propen-1-ones as antimalarial agents.
 M. Satyanarayana et. al.,75  have synthesized 1,3-disubstituted-2-
propen-1-ones  as antihyperglycemic agents (II). O. Sahzevari et al.76  have
synthesized 1,3-disubstituted-2-propen-1-ones as anticancer agent, which are
particulary cytotoxic towards K562 leukemia cells. Furthermore, M. J. Alcaraz
et. al.,77 have described the role of nuclear factor kappa-β and heme-
oxygenase-1 in the action of an antiinflammatory 1,3-disubstituted-2-propen-








 O. Nerya et. al.,78 have prepared some new 1,3-disubstituted-
2-propen-1-ones as potent tyrosinase inhibitors.  O. Sabzevari et. al.,79 have
reported some new 1,3-disubstituted-2-propen-1-ones as Molecular cytotoxic
mechanisms of anticancer hydroxy chalcones (III). F. Hollosy et. al.,80 have
prepared some new 1,3-disubstituted-2-propen-1-ones as Plant-derived
protein tyrosine kinase inhibitors.






Recently,  H. S. Ban et. al.,81 have reported some newer 1,3-disubstituted-
2-propen-1-ones as inhibition of lipo poly saccharide-induced expression of
inducible nitric oxide synthase and tumor necrosis factor-α by 2'-hydroxy
chalcone derivatives in RAW 264.7 cells. S. Feldbaek Nielsen et. al.,82 have










P. P. Yadav et. al.,83 have synthesized nitrogen and sulfur containing








J. N. Dominguez et. al.,84 have synthesized 1,3-disubstituted-2-propen-
1-ones  and reported their activity as  antimalerial agents.
23Part - I, Introduction ...,   “ Studies on 1,3-disubstituted-2-propene-1-ones”.
W. Duck Seo et. al.,85 have synthesized 1,3-disubstituted-2-propen-1-







M. Larsen and et. al.,86 have synthesized 1,3-disubstituted-2-propen-1-






Moreover,  S. Khatib et. al.,87 have reported some novel 1,3-
disubstituted-2-propen-1-ones as potent tyrosinase inhibitors (VIII). Seo et.








A. Araico  et. al.,89 have synthesized 1,3-disubstituted-2-propen-1-ones
as inhibitor of cyclo-oxygenase-2 and 5-lipoxygenase.
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 S. H. L. et. al.,90 have designed and synthesized some new 1,3-
disubstituted-2-propen-1-ones and reported their antiinflammatory activity.
 P. Boeck et. al.,91 have synthesized some newer 1,3-disubstituted-2-
propen-1-ones  (IX) with antileishmanial activity, in which analogues contain
nitro, fluorine or bromine group respectively displayed increased selectivity
against the parasites as compared with natural 1,3-disubstituted-2-propen-1-
ones.  X. Wu et. al.,92 have synthesized ferrrocenyl 1,3-disubstituted-2-propen-











    R. R. Kamble et. al.,93 have reported novel 1,3-disubstituted-2-









M. S. Yar et. al., 94  have synthesised some 1,3-disubstituted-2-propen-






F. Jin et. al.,95 have reported structural requirments of synthetic
derivative of butein, a natural 1,3-disubstituted-2-propen-1-ones (XII) foranti-
inflammatory activity.




These valid observations about the therapeutic applications of 1,3-
disubstituted-2-propen-1-ones led us to explore chemistry and biological
activities of 1,3-disubstituted-2-propen-1-ones by synthesizing their several
derivatives viz., bromochalcones,  epoxides, pyridine carbonitriles,
cyclohexenones,  benzodiazepines,  benzothiazepines a n d
benzoxazepines which can be summarised in the following sections.
SECTION-I :   SYNTHESIS AND THERAPEUTIC EVALUATION OF   1-
    SUBSTITUTED PHENYL-3-(m-PHENOXYPHENYL)-2-
    PROPEN-1-ONES.
SECTION-II :  PREPARATION AND BIOLOGICAL EVALUATION OF 2,3-
   DIBROMO-3-(m-PHENOXYPHENYL)-1-SUBSTITUTED
   PHENYL PROPAN-1-ONES.
SECTION-III :  PREPARATION AND BIOLOGICAL EVALUATION  OF  3-(m-
    PHENOXYPHENYL) -OXIRAN-2-YL-SUBSTITUTED
    PHENYLMETHANONES.
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SECTION - I
PREPARATION AND BIOLOGICAL SCREENING OF 1-SUBSTITUTED
PHENYL-3-(m-PHENOXYPHENYL)-2-PROPEN-1-ONES.
In view of various biodynamic activities35-55 of 1-substituted phe-
nyl-3-(m-phenoxyphenyl)-2-propen-1-ones  and with a view to have po-
tent therapeutic agents, the synthesis of 1-substituted phenyl-3-(m-
phenoxyphenyl)-2-propen-1-ones (Ia-j) have been undertaken by the con-







The constitution of the products (Ia-j) have been delineated by elemen-
tal analyses, IR, PMR and Mass spectral data.
The products (Ia-j) were assayed for their in vitro biological assay like
antibacterial activity towards S. pyogens MTCC-442, S. aureus MTCC-
96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-443 (Gram
negative) bacterial strain and antifungal activity towards A. niger  MTCC-
282 and C. albicans MTCC-227 fungii at different concentrations i.e. : 0 (con-
trol), 5, 25, 50, 100, 250 (μg/ml). The biological activities  of the synthe-
s ized  compounds  (Ia-j) were  compared  w i th  s tandard  d rugs  viz.
Amoxicillin, Chloramphenicol, Sparfloxacin, Levofloxacin (antibacterial)
and Griseofulvin, Fluconazole (antifungal).
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REACTION SCHEME
 (Ia-j)
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENING OF 1-SUBSTITUTED
PHENYL-3-(m-PHENOXYPHENYL)-2-PROPEN-1-ONES.
(A) Preparation of 1-(p-methoxy phenyl )-3-(m-phenoxyphenyl)-2-
propen-1-one (Ij).
A mix ture  o f  p-methoxyacetophenone (1 .50 gm,  0 .01 M) , m-
phenoxybenzaldehyde (1.98 ml, 0.01 M) in methanol (40ml) and aqueous
potassium hydroxide (40%, 2ml) were stirred for 24 hrs. at  room temprature.
The content was poured on crushed ice and neutralized with Conc. hydrochlo-
ric acid. The  product   was isolated and crystallized from dioxane:methanol
(1:2). Yield : 72%, M.P. :121°C,  (Required :  C: 80.0%; H: 5.45%  for
C22H18O3, Found : C: 79.94%; H: 5.40% ).
TLC solvent system  Rf1 : Ethyl acetate : Cyclohexane(2.0 : 8.0) = 0.46
TLC solvent system  Rf2 : Acetone          : Benzene(1.5 : 8.5)        = 0.58
Similarly, other compounds (Ia-j) were synthesized. The physical data
are recorded in Table No. 1.
(B) Antimicrobial activity of 1-substituted phenyl-3-(m-phenoxy -
phenyl)-2-propen-1-ones (Ia-j).
Antimicrobial activity testing was carried out by using cup-plate
method96, which has been described as under.
 * Antimicrobial activity
S. pyogens MTCC-442 and S. aureus MTCC-96 (Gram positive
bacteria) were grown in nutrient broth and E. coli MTCC-443 and B. subtillis
MTCC-441 (Gram negative bacteria) in Peptone water (PW, 1% bacteriologi-
cal peptone and 0.5% sodium chloride in water) for 24 hrs., this gave an opti-
Part - I,  Section - I...,  “Studies on 1,3-disubstituted-2-propen-1-ones”. 29
mum growth of the test  bacteria. Each purified compound was dissolved in
dimethyl formamide sterilized by filtration by using sintered glass filter and
stored at 4°C. Each agent was then added to molten nutrient agar in the fol-
lowing concentrations i.e. : 0 (control), 5,25, 50,100, 250 (μg/ml) and poured
into sterile petri dished. The pH of the medium was maintained in between
7.2 to 7.4. The inoculum consisted of an overnight grown broth culture of a
bacterium diluted in such a manner that a 2 m.m. (internal diameter) loopful of
the culture contain 105 colony-forming unit (CFU). These were then spot in-
oculated on nutrient  agar  plates containing increasing amount of a com-
pound, incubated at 37°C up to 24 hrs. for determination of the minimum
inhibitory concentration97,98 (MIC). Which are recorded in zones of inhibition
in m.m. for bacterias.
   * Antifungal activity
C. albicans MTCC-227 and A. niger MTCC-282 was employed for
testing antifungal activity using cup-plate method. The culture was maintained
on Sabouraud's agar for 72 hrs., this gave an optimum growth of the test fun-
gal spores. Each purified compound was dissolved in dimethyl formamide ster-
ilized by filtration by using sintered glass filter and stored. Each agent was
then added to Sabouraud's agar in the following concentrations i.e. 0 (con-
trol), 5, 25, 50, 100, 250 (μg/ml) and poured into sterile petri dished. The in-
oculum consisted of an overnight grown broth culture of a bacterium diluted
in such a manner  so that a 2 mm (internal diameter) loopful of the culture
contain 105 colony-forming unit (CFU). These were then spot inoculated on
Sabouraud's agar plates containing increasing amount of a compound, incu-
bated at 37°C for 48 hrs. for determination of the minimum inhibitory concen-
tration (MIC)97,98. The MIC values of test solutions are recorded in Table No.
1a, 1b and 1c., which are recorded in zones of inhibition in m.m. for fungii.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)





































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
IR  SPECTRAL  STUDY  OF  1-(p-METHOXY PHENYL)-3-(m-PHENOXY -
PHENYL)-2-PROPEN-1-ONE (Ij).
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)





































IR  SPECTRAL  STUDY  OF  1-(p-METHYL PHENYL)-3-(m-PHENOXY-
PHENYL)-2-PROPEN-1-ONE (Ii) .
* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)




C-F (str., s, b)




























IR  SPECTRAL  STUDY  OF  1-(p-FLUORO PHENYL)-3-(m-PHENOXY-
PHENYL)-2-PROPEN-1-ONE (Ic).
* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)




C-Cl (str., s, b)




























IR  SPECTRAL  STUDY  OF  1-(p-CHLORO PHENYL)-3-(m-PHENOXY-
PHENYL)-2-PROPEN-1-ONE (Ib).
* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)



































IR  SPECTRAL  STUDY  OF  1-(p-METHYL PHENYL)-3-(m-PHENOXY-
PHENYL)-2-PROPEN-1-ONE (Ih).
* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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m/z =166.5(M+1), m/z =140.5(M-1),










 C16H14O2  C21H20O
( B.P.),
(Ib)
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SECTION - II
PREPARATION AND BIOLOGICAL EVALUATION OF 2,3-DIBROMO- 3-(m-
PHENOXYPHENYL)-1-SUBSTITUTED PHENYL PROPAN-1-ONES.
In view of various biodynamic activities35-55of dibromo chalcones
and with a view to have potent therapeutic agents, the synthesis of dibromo
chalcones of type (IIa-j) have been synthesised by the bromination of 1-sub-










    (Ia-j)       (IIa-j)
R= Substituted phenyl
The constitution of the products (IIa-j) have been delineated by elemen-
tal analyses, IR, PMR and Mass spectral data.
The products (IIa-j) were assayed for their in vitro biological assay like
antibacterial activity towards S. pyogens MTCC-442, S. aureus MTCC-
96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-443 (Gram
negative) bacterial strain and antifungal activity towards A. niger  MTCC-
282 and C. albicans MTCC-227 fungii at different concentrations i.e.   0 (con-
trol), 5, 25, 50, 100, 250 (μg/ml). The biological activit ies  of  the synthe-
s ized compounds (IIa-j) were  compared wi th  s tandard  drugs  viz.
Amoxicillin, Chloramphenicol, Sparfloxacin, Levofloxacin (antibacterial)
and Griseofulvin, fluconazole (antifungal).
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REACTION SCHEME
(IIa-j)
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL EVALUATION OF 2,3-DIBROMO-3-(m-
PHENOXYPHENYL)-1-SUBSTITUTED PHENYL PROPAN-1-ONES.
 (A) Preparation of 1-substituted phenyl-3-(m-phenoxyphenyl)-2-
propen-1-ones (Ia-j).
For preparation, refer  Section - I,  Page No. 28.
(B) Preparation of 2,3-dibromo-3-(m-phenoxyphenyl)-1-(p-methoxy
phenyl)-propan-1-one (IIj).
The 1-(p-methoxy phenyl )-3-(m-phenoxyphenyl)-2-propen-1-one
(Ij) (3.30gm,0.01M) was dissolved in acetic acid and bromine in acetic acid
(1 ml, 10%) was slowly added to it.The reaction mixture was stirred for an
hour. Then it was poured over crused ice. The separated solid was collected,
washed with distilled water, dried and crystallised from chloroform:methanol
(1:1) mixture. Yield : 63%, M.P. : 110°C,   (Required :  C: 53.91%; H: 3.70%
for C22H18Br2O3, Found : C: 53.89%; H: 3.68% ).
TLC solvent system  Rf1  :  Ethyl acetate : Cyclohexane(3.1 : 6.9) = 0.58
TLC solvent system  Rf2  :  Acetone          : benzene(2.4 : 7.6)         = 0.62
Similarly, other compounds (IIa-j) were synthesized. The physical
data are recorded in Table No. 2.
(C) Antimicrobial activity of 2,3-Dibromo-3-(m-phenoxyphenyl)-1sub
stituted phenyl propan-1-ones (IIa-j).
Antimicrobial activity testing was carried out as described in section-I,
page No. 28. The zones of inhibition of test solution are recorded in Table
No. 2a, 2b and 2c.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str., s)
C-O-C(sym. str.,  s)
C=O (str., m)
C-Br (str., s)



































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
























Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)
C=O (str., m)
C-Br (str., s)
C-Cl (str., s, b)






























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)
C=O (str., m)
C-Br (str., s)



































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.






























































































































































Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)




































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.


























































































































































Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)
C=O (str., m)
C-Br (str., s)
C-F (str., s, b)
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* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.













































































































































































































































































































































































































































































































































































































































































































































































































































































































m/z =424(M+2), m/z =457(M+1),
m/z =376,
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SECTION - III
PREPARATION AND BIOLOGICAL SCREENIG  OF  3-(m-PHENOXYPHENYL)-
OXIRAN-2-YL-SUBSTITUTED PHENYL METHANONES.
The chemistry of oxiranes has assumed importance because of their
versatility in the synthesis of many heterocycles and polymeric compounds.
Futhermore epoxides are also associated with wide spectrum of biological
activities.  With a view to have potent therapeutic agents, the synthesis of  3-
(m-phenoxyphenyl)-oxiran-2-yl-substituted phenyl methanones(IIIa-j)
have been undertaken by the oxidation of 1-Substituted phenyl-3-(m-
phenoxyphenyl)-2-propen-1-ones (Ia-j) using alkaline hydrogen perox-














The constitution of the products (IIIa-j) have been delineated by elemen-
tal analyses, IR, PMR and Mass spectral data.
The products (IIIa-j) were assayed for their in vitro biological assay
like  antibacterial activity towards S. pyogens MTCC-442, S. aureus
MTCC-96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-
443 (Gram negative) bacterial strain and antifungal activity towards A. niger
MTCC-282 and C. albicans MTCC-227 fungii at different concentrations i.e.
0 (control), 5, 25, 50, 100, 250 (μg/ml). The biological activit ies  of  the
synthesized compounds (IIIa-j) were compared with standard drugs viz.
Amoxicillin, Chloramphenicol, Sparfloxacin, Levofloxacin (antibacterial)
and Griseofulvin, Fluconazole (antifungal).
(IIIa-j)
 R=Substituted phenyl


















 R = Substituted phenyl
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENIG  OF  3-(m-PHENOXY PHE-
NYL)-OXIRAN-2-YL-SUBSTITUTED PHENYL METHANONES.
(A) Preparation of 1-substituted phenyl-3-(m-phenoxyphenyl)-2-
propen-1-ones (Ia-j).
For preparation, refer Section - I, Page No. 28.
(B) Preparation of  3-(m-phenoxyphenyl)-oxiran-2-yl-(p-methoxy
phenyl)-methanone.(IIIj).
A mixture of 1- (p-methoxyphenyl)-3 - (m-phenoxyphenyl)-2-
propen-1-one (Ij) (3.30gm,0.01M) and alkaline hydrogen peroxide, 30%
(0.34 g, 0.01 M) in tetrahydrofuran were stirred at room temperature for 24
hours.The resulting mixture then left overnight at room temperature.After dis-
tillation of the solvent, the product was isolated and crystallized from metha-
nol.  Yield : 61%, M.P. : 136°C,   (Required :  C: 76.29%; H: 5.20%  for
C22H18O4, Found : C: 76.26%; H: 5.17% ).
 TLC Solvent  System : Rf1   : Ethyl acetate : Cyclohexane(3.0 : 7.0)   =  0.47 TLC Solvent  System : Rf2  :  Acetone          : Benzene(2.6 : 7.4)           =  0.49
Similarly, other compounds (IIIa-j) were synthesized. The physical
data are recorded in Table No.3.
(C) Antimicrobial activity of  3-(m-phenoxyphenyl)-oxiran-2-yl-
substituted phenyl methanones (IIIj).
Antimicrobial activity testing was carried out as described in section-I,
page No. 28. The zones of inhibition of test solution are recorded in Table
No. 3a, 3b and 3c.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)
C C
O
    (sym. str., s)
C=O (str., m)
C-F (str., s, br)
C-H (def., v, s)




























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)
C C
O
    (sym. str., s)
C=O (str., m)
C-Cl (str., s, br)
C-H (def., v,s)




























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)
C C
O




C-H (def., v, s)





























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)
C C
O
    (sym. str., s)
C=O (str., m)
C-H (def., v, s)

































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)
C-O-C (sym. str., s)
C C
O
    (sym. str., s)
C=O (str., m)
C-H (def., v, s)

































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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 C14H14O  C15H16O3
( B.P.),
(III-b)
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PART- II
STUDIES ON 2 ,4 ,6 -TRISUBSTITUTED-3-CYANO PYRIDINES.
INTRODUCTION
Pyridine nucleus which is substituted at 2,4,6 position by alkoxy and
diaryl groups and 3-position by nitrile group is called 2,4,6-trisubstituted-3-
cyano pyridine.
Cyanopyridine derivatives can be synthesized from corresponding
methylpyridines by oxidation in the vapour phase with air and ammonia and
these are useful materials for the synthesis of other substituted pyridines. For
example, hydrolysis of 3-cyanopyridine gives pyridine-3-carboxamide
(nicotinamide) and pyridine-3-carboxylic acid (nicotinic acid) of the B group
of vitamins. Pyridine-3-carboxamide (nicotinamide) occurs as a component
of the structure of the important coenzymes nicotinamide adenine dinucleotide
(NAD+, R = H), and its phosphate [NADP+ , R= PO(OH)2] (I) . The latter
coenzyme, one of the B2 complex of vitamins, occurs in red blood corpuscles
and participates in biochemical redox reactions.
Pyridoxol (vitamin B6, R=CH2OH) (II), occurs in yeast and wheatgerm
and is an important food additive. Related compounds with common trivial
names are pyridoxal (R=CHO) and pyridoxamine (R=CH2NH2).The 5-phosphate
of pyridoxal is a coenzyme in decarboxylation and transamination reactions of
α-amino acids. There are many other naturally occuring pyridines, the tobacco
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Cyanopyridine derivatives also possess other activities like pesticidal99,
insecticidal100, fungicidal.101
SYNTHETIC ASPECT
Several methods for the preparation of 3-cyanopyridines are reported
in literature.102-108 Some of the well known methods are as under,
1. By the condensation of α,β-unsaturated ketones with malononitrile
in presence of ammonium acetate.109,110,115,116
2. By cyclocondensation of cyanoacetamide with ethyl acetoacetate in
presence of base.111
3. By the reaction of 3-substituted phenyl pyrazolone derivatives with
malononitrile.112
4 By the reaction of arylidene malanonitrile with lithium isopropyl amide
in dimethyl formamide-dichloromethane.113,114
5. By the vapour phase air oxidation of nicotine over V2O5117 or alkenyl
substituted pyridines in presence of ammonia and V-Mo-P catalyat.118
6.` By the reaction of pyridine-3-carboxylic acid with ammonia in the
presence of dehydrating catalyst at 275°C to 450 °C.119,120
7. By heating potassium salt of 3-pyridine-sulphonic acid with sodium
cyanide at 350°C to 400 °C.121
8. By heating pyridine-3-carboxamide in the presence of TiCl4 and a base
trimethyl amine at 0 °C.122
9. By the reaction of an alkalicyanide with 3-pyridine sulphonate123 or 3-
bromo pyridine.124
MECHANISM
The reaction mechanism includes the formation of nucleophile (a) from
malanonitrile in the presence base. The nucleophile undergoes nucleophilic
addition with α,β-unsaturated ketone give intermidiate (b) which undergoes
intramolecular condesation in the presence of the base between oxygen of
ketone and nitrogen of nitrile group gives cyclised product (c). Dehydration of
cyclised product (c) gives final product (d).






























































Literature survey revealed that various cyanopyridine derivatives








9.   Anticonvulsant132





E. Francis et.al.,139 have studied the effect of some substituted
pyridines on the growth of the walker carcinosarcome-256 in tissue culture. A.
Streightoff140and J.Seydal142have studied the bacteriostatic effect of some
substituted 3-cyanopyridines.  K. Kadlec et.al.,141 showed that 2-methyl-3-
nitro-4-methoxyethyl-5-cyano-6-chloro pyridines caused occupational eczema
in Vitamin B6 factory workers. W. Hoefling et.al.,143 have studied 3 and
4-cyanopyridines as tuberculosis arresting agents. J. A. Vann Allan et.al.,144
have prepared fused heterocyclic 3-cyanopyridine (III) as antiinflammatory








J.J.Baldwin146,147,151  have prepared cyanopyridines exhibiting
antihypertensive activity. V. Scott and E. Joseph148,149 have prepared 2-
amino-3-cyanopyridine derivatives which were found to be useful as
antipsoriasis pharmaceuticals.   Dipeptidyl peptidase (DPP-IV) inhibition has
the potential to become a valuable therapy for diabetes.
 N. Latif et.al.,150 have reported the antibacterial and antifungal activity
of 2-amino-3-cyano-4,6-disubstituted pyridines. W. V. benbenburg et.al.,152
have synthesized 2-amino-3,6- disubstituted pyridines as antiepileptic agents.
3-cyanopyridines reported by L. Castedo et.al.,153 showed a minimum
inhibitory concentration of 1.56 μg/ml against S. aureus.  M. R. Pavia et.al.,154
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have prepared N-substituted 2- aminopyridines which possess anticonvulsant
property. J. Schaefer et. al.,155 have prepared 3-cyanopyridines as  potential
carditonic agents.
 S. Pietro et. al.,156 have synthesized 2-substituted 5-cyano-1,6-dihydro-
6-oxo-3-pyridinecarboxylic acids and their methyl or ethyl esters (IV) and
reported their appreciable inotropic activity.  D.J.Triggle157 has prepared
ethyl-5-cyano substituted pyridinecarboxylate possessing calcium channel
blocking and positive intropic activity.  M. Bernard et.al.,158 have reported
the anticonvulsant activity of 3-cyanopyridines. D. G. Bhatt et.al.,159 have
prepared 3-cyanopyridines as an immunosuppressive agent. S. Guru et.al.,160



















    J. A. Tucker et.al.,161  have synthesized novel Piperazinyl Oxazolidinone
containing cyanopyridine (VI) as an antibacterial agents. H. Yoshida et.al.,162










G. S. Gadaginamath et.al.,163 have synthesized various cyanopyridyl
derivatives (VII) and evaluated their variety antifungal activities. M. Fedele
et.al.,164 have reported the antiinflammatory activity of 3-cyanopyridines.
E. G.Hammana Abou et.al.,165 have studied anticancer and anti-HIV activity
of 3-cyanopyridine derivatives. N. A. Abdallah  et.al.,166  have prepared
cyanopyridine derivatives having analgesic and antiinflammatory activity.











A. El-Galil et.al.,167 have prepared 3-cyanopyridines (VIII) and studied
their antidepressant activity.  El-Nabawia et.al.,168 have prepared 2-amino-














V. H.Shah et.al.,169 have synthesized 2-amino-3-cyano-4-(m-




NH2R R= Substituted phenyl
(X)
S. V. Roman et.al.,170 have synthesized 2-amino-3-cyanopyridines and
reported their analgesic activity. F.M.A. El-Taweel et.al.,171 have prepared
cyanopyridine derivatives and showed their significant antihypertensive activity.
U. D. Pyachenko  et.al.,172 have synthesized some cyanopyridines which are
useful in the treatment of retroviral disease. B.Abu-Shana et. al.,173 have
prepared novel fused cyanopyridines (X) for the treatment and preparation of
systemic fungal infection. E.B. Villhauer et. al.,174 have reported the first use
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of solid-phase synthesis in the discovery of a new DPP-IV inhibitor class and
a solution-phase synthesis that is practical up to the multikilogram scale.
J.L.Marco et.al.,175 have synthesized cyanopyridine and reported as
acetylcholinesterase inhibitors. R.Ulrich et.al.,176 have synthesized a new
cyanopyridine as receptor agonists in the treatment of cardiac or urogenital














(XI)  (XII)  R1,R2 =Substitted
 phenyl
M. A.Moustafa et.al.,177 have prepared cyanopyridine as
antibacterial agents. H. S. Joshi et. al.,178 have synthesized cyanopyridines
and screened for their anticancer, antitubrcular and antimicrobial activities.
E.H.S. Sousa et.al.,179 documented thionicotinamide coordinated to the a
model system for the in vitro activation of thioamides antituberculosis drugs.
G.T. Wang et.al.,180 have synthesized o-trifluoro methylbiphenyl substituted 2-
amino-nicotinonitriles as inhibitors of farnesyl transferase(XIII). A.Z.A.















(XIII) R1,R2=Substituted phenyl         (XIV)
A.G. E. Amr et.al.,182 have synthesized heterocyclic  pyridine deriva-
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tives (XV) fused with steroidal structure as antiinflammatory agents. Initially
the acute toxicity of the compounds was assayed via the determination of their











A. M. Moustafa et.al.,183 has synthesised benzocycloheptal-[1,2-b]-pyridine
carbonitrile derivatives (XVI)  based on its antiinflammatory activity and to treating







In view of therapeutic activities shown by cyanopyridines, it was contemplated
to synthesize some new cyanopyridines in search of agents possessing higher
biological activity  with least side effect have been described  as under.
SECTION-I : PREPARATION AND BIOLOGICAL EVALUATION OF 2-
ETHOXY-4-SUBSTITUTED PHENYL-6-(m-PHENOXY
PHENYL)-NICOTINO NITRILES.
SECTION-II : PREPARATION AND BIOLOGICAL EVALUATION OF 2-
BUTOXY-4-SUBSTITUTED PHENYL-6-(m-PHENOXY
PHENYL)-NICOTINO NITRILES.
SECTION-III : PREPARATION AND BIOLOGICAL EVALUATION OF 2-
ISOPROPOXY-4-SUBSTITUTED PHENYL-6-(m-
PHENOXYPHENYL)-NICOTINO NITRILES.
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SECTION - I
PREPARATION AND BIOLOGICAL SCREENING OF 2-ETHOXY-4-SUB-
STITUTED PHENYL-6-(m-PHENOXYPHENYL)-NICOTINO NITRILES.
Due to various biodynamic activities125-138of  2,4,6-trisubstituted-
3-cyano pyridines and with a view to have potent therapeutic agents, the
synthesis of 2-ethoxy-4-substituted phenyl-6-(m-phenoxy phenyl)-
nicotino nitriles (IVa-j) have been undertaken by the condensation of 1-Sub-
stituted phenyl-3-(m-phenoxy phenyl)-2-propen-1-ones(Ia-j). with














The constitution of the products (IVa-j) have been delineated by
elemental analyses, IR, PMR and Mass spectral data.
The products (IVa-j) were assayed for their in vitro biological assay
like  antibacterial activity towards S. pyogens MTCC-442, S. aureus
MTCC-96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-
443 (Gram negative) bacterial strain and antifungal activity towards A. niger
MTCC-282 and C. albicans MTCC-227 fungii at different concentrations i.e.
0 (control), 5, 25, 50, 100, 250 (μg/ml). The biological activit ies  of  the
synthesized compounds (IVa-j) were compared with standard drugs viz.
Amoxicillin, Chloramphenicol, Sparfloxacin, levofloxacin (antibacterial)
and Griseofulvin, Fluconazole (antifungal).



















R = Substituted phenyl
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENING OF 2-ETHOXY- 4-SUB-
STITUTED PHENYL-6-(m-PHENOXYPHENYL)-NICOTINO NITRILES.
(A) Preparation of 1-(p-methoxy phenyl )-3-(m-phenoxy phenyl)-2-
propen-1-one (Ij).
For preparation,  refer  Part - I, Section- I,  Page No. 28.
(B) Preparation of 2-ethoxy-4-(p-methoxy phenyl)-6-(m-phenoxy phe
nyl)-nicotino nitrile (IVj).
A mixture of 1-(p-methoxy phenyl)-3-(m-phenoxy phenyl)-2-
propen-1-one (3.30gm,0.01M), malanonitrile (0.60gm,0.01M) in ethanol
(10ml) was refluxed under stirring for10-12 hours in presence of sodium
ethoxide, prepared from sodium (46mg, 2.0M) and absolute ethanol (5 ml).
The reaction mixture was diluted with water and extracted with chloroform.
The excess solvent was distilled off and residue was crystallised from ethanol.
Yield :63%, M.P. : 164°C,  (Required :  C: 76.76%; H: 5.25%  for C27H22N2O3,
Found : C: 76..71%; H: 5.20% ).
TLC Solvent system Rf1   :   Ethyl : Cyclohexane (3.2 :6.8)  =  0.56
TLC Solvent system Rf2   :   Acetone : Benzene   (2.0 :8.0)  =  0.53
Similarly, other compounds (IVa-j) were synthesized. The physical
data are recorded in Table No.4.
(C) Antimicrobial activity of 2-ethoxy-4-substituted phenyl-6-(m-phe-
-noxy phenyl)-nicotino nitriles (IVa-j).
Antimicrobial activity testing was carried out as described in part-I, sec-
tion-I, page No. 28. The zones of inhibition of test solution are recorded in
Table No. 4a,4b and 4c.








































































































   




































   



































   





































   





































   







































   





































   

































   





   





































   






































   
























































Part - II Section - I..., “Studies on 2,4,6-trisubstituted-3-cyano pyridines”. 126

































































































































































Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str., s)




C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-ETHOXY-4-(p-METHYL PHENYL)-6-






































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str., s)




C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-ETHOXY-4-(p-METHOXY PHENYL)-6-





































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str., s)
C-O-C (sym. str., s )
C≡N (str., m)
C=N (str., v, b)
C-N (str., s)
C-F (str., s, b)
C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-ETHOXY-4-(p-FLUORO PHENYL)-6-












    1510.31-
1645.33
1101.39

























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C(asym.str., s)




C-Cl (str., s, b)
C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-ETHOXY-4-(p-CHLORO PHENYL)-6-









































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C(asym.str., s)






C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-ETHOXY-4- (p-NITRO PHENYL)-6-












    1510.31-
1604.83




























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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PMR  SPECTRAL  STUDY  OF  2-ETHOXY-4-(p-METHYL PHENYL)-6-
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PMR  SPECTRAL  STUDY  OF  2-ETHOXY-4-(p-METHOXY PHENYL)-6-
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PMR  SPECTRAL  STUDY  OF  2-ETHOXY-4-(p-FLUORO PHENYL)-6-
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PMR  SPECTRAL  STUDY  OF  2-ETHOXY-4-(p-CHLORO PHENYL)-6-
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PMR  SPECTRAL  STUDY  OF  2-ETHOXY-4-(p-NITRO PHENYL)-6-



































































































































































































 C8H11NO  C6H6
 C12H8N2
(IVi)
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SECTION - II
PREPARATION AND BIOLOGICAL SCREENING OF 2-BUTOXY-4-
SUBSTITUTEDPHENYL-6-(m-PHENOXYPHENYL)-NICOTINO NI-TRILES.
Due to various biodynamic activities125-138 of 2,4,6-trisubstituted-
3-cyano pyridines and with a view to have potent therapeutic agents, the
synthesis of 2-butoxy-4-substituted phenyl-6-(m-phenoxy phenyl)-
nicotino nitriles(Va-j) have been undertaken by the condensation of 1-
substitutedphenyl-3-(m-phenoxy phenyl)-2-propen-1-ones(Ia-j). with













  R=Substituted phenyl
The constitution of the products (Va-j) have been delineated by elemen-
tal analyses, IR, PMR and Mass spectral data.
The products (Va-j) were assayed for their in vitro biological assay
like  antibacterial activity towards S. pyogens MTCC-442, S. aureus
MTCC-96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-
443 (Gram negative) bacterial strain and antifungal activity towards A. niger
MTCC-282 and C. albicans MTCC-227 fungii at different concentrations i.e.
0 (control), 5, 25, 50, 100, 250 (μg/ml). The biological activit ies  of  the
synthesized compounds (Va-j) were compared with standard drugs viz.
Amoxicillin, Chloramphenicol, Sparfloxacin, Levofloxacin (antibacterial)
and Griseofulvin, Fluconazole (antifungal).
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REACTION SCHEME
 (Va-j)
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENING OF 2-BUTOXY- 4-S U B -
STITUTED PHENYL-6-(m-PHENOXYPHENYL)-NICOTINO NITRILES.
(A) Preparation of 1-(p-methoxy phenyl )-3-(m-phenoxy phenyl)-2-
propen-1-one (Ij).
For preparation,  refer  Part - I,  Section - I, Page No. 28.
(B) Preparation of 2-butoxy-4-(p-methoxy phenyl)-6-(m-phenoxy phe
nyl)-nicotino nitrile (Vj).
A mixture of 1-(p-methoxy phenyl)-3-(m-phenoxy phenyl)-2-
propen-1-one (3.30gm,0.01M), malanonitrile (0.60gm,0.01M) in butanol
(10ml) was refluxed under stirring for 10-12 hours in presence of sodium bu-
toxide, prepared from sodium (46mg, 2.0M) and absolute butanol (5 ml). The
reaction mixture was diluted with water and extracted with chloroform. The
excess solvent was distilled off and residue was crystallised from ethanol.
Yield : 62%, M.P. : 191°C,  (Required : C : 77.31%; H: 5.82%  for C29H26N2O3,
Found : C: 77.27%; H: 5.78% ).
TLC solvent system Rf1    : Ethyl acetate : Cyclohexane (3.1 :6.9)   =  0.44
TLC solvent system Rf2    : Acetone          : Benzene         (2.2 :7.8)   =  0.47
Similarly, other compounds (Va-j) were synthesized. The physical
data are recorded in Table No. 5.
(C) Antimicrobial activity of 2-butoxy-4-substituted phenyl-6-(m-
phenoxy phenyl)-nicotino nitriles (Va-j).
Antimicrobial activity testing was carried out as described in part-I, sec-
tion-I, page No. 28. The zones of inhibition of test solution are recorded in
Table No.5a, 5b and 5c.











































































































































   



































   


































   




































   




































   






































   




































   
































   





   




































   





































   

















































































































































Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str., s)




C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-BUTOXY-4-(p-METHYL PHENYL)-6-












    1518.03-
1627.97
























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str., s)




C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-BUTOXY- 4-(p-METHOXY PHENYL)- 6-












    1512.24-
1602.90
























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)




C-F (str., s, b)
C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-BUTOXY-4-(p-FLUORO PHENYL)-6-








































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.








































































































































Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C(asym.str.,s)




C-Cl (str., s, b)
C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-BUTOXY-4-(p-CHLORO PHENYL)-6-












   1519.96-
    1589.40



























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m, s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str., s)






C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-BUTOXY-4-(p-NITRO PHENYL)-6-(m-












    1501.31-
1635.69




























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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PMR  SPECTRAL  STUDY  OF  2-BUTOXY-4-(p-METHYL PHENYL)-6-
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PMR  SPECTRAL  STUDY  OF  2-BUTOXY- 4-(p-METHOXY PHENYL)-6-
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PMR  SPECTRAL  STUDY  OF  2-BUTOXY-4-(p-FLUORO PHENYL)-6-
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PMR  SPECTRAL  STUDY  OF  2-BUTOXY- 4-(p-CHLORO PHENYL)-6-























































































Part-II, Section -II..., “Studies on 2,4,6-trisubstituted-3-cyano pyridines”. 162
PMR  SPECTRAL  STUDY  OF  2-BUTOXY-4-(p-NITRO PHENYL)-6-
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13C SPECTRAL  STUDY  OF  2-BUTOXY-4-(p-METHOXY PHENYL)-6-
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SECTION - III
PREPARATION AND BIOLOGICAL SCREENING OF 2-ISOPROPOXY-
4-SUBSTITUTEDPHENYL-6-(m-PHENOXYPHENYL)-NICOTINO NI-
TRILES.
Due to various biodynamic activities125-138 of 2,4,6-trisubstitued-
3-cyano pyridines and with a view to have potent therapeutic agents, the
synthesis of 2-isopropoxy-4-substituted phenyl-6-(m-phenoxy phenyl)-
nicotino nitriles(VIa-j) have been undertaken by the condensation of 1-sub-
stituted phenyl-3-(m-phenoxy phenyl)-2-propen-1-ones(Ia-j). with















  R=Substituted phenyl
The constitution of the products (VIa-j) have been delineated by elemental
analyses, IR, PMR and Mass spectral data.
The products (VIa-j) were assayed for their in vitro biological assay
like  antibacterial activity towards S. pyogens MTCC-442, S. aureus
MTCC-96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-
443 (Gram negative) bacterial strain and antifungal activity towards A. niger
MTCC-282 and C. albicans MTCC-227 fungii at different concentrations  i.e.
0 (control), 5, 25, 50, 100, 250 (μg/ml). The biological activit ies  of  the
synthesized compounds (VIa-j) were compared with standard drugs viz.
Amoxicillin, Chloramphenicol, Sparfloxacin, Levofloxacin (antibacterial)
and Griseofulvin, Fluconazole (antifungal).
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REACTION SCHEME
(VIa-j)
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENING OF 2-ISOPROPOXY-4-
SUBSTITUTED PHENYL-6-(m-PHENOXYPHENYL)-NICOTINO NITRILES.
(A) Preparation of 1-(p-methoxy phenyl )-3-(m-phenoxy phenyl)-2-
propen-1-one (Ij).
For preparation, refer Part -I , Section - I, Page No.28.
(B) Preparation of 2-isopropoxy-4-(p-methoxyphenyl)-6-(m-phenoxy
phenyl)-nicotino nitrile (VIj).
A mixture of 1- (p-methoxy phenyl)-3- (m-phenoxyphenyl)-2-
propen-1-one (3.30gm,0.01M), malanonitrile (0.60gm,0.01M) in isopropyl
alcohol (10ml) was refluxed under stirring for10-12 hours in presence of so-
dium isopropoxide, prepared from sodium (46mg, 2.0M) and absolute
isopropoyl alcohol (5 ml). The reaction mixture was diluted with water and ex-
tracted with chloroform. The excess solvent was distilled off and residue was
crystallised from ethanol.   Yield :64%, M.P. : 183°C,  (Required :C: 77.04%; H:
5.54%  for C28H24N2O3, Found : C: 77.00%; H: 5.49% ).
TLC solvent system  Rf1 : Ethyl acetate : Cyclohexane(3.3 :6.7)  = 0.69
TLC solvent system  Rf2 : Acetone         : benzene    (1.8 :8.2)  = 0.67
Similarly, other compounds (VIa-j) were synthesized. The physical
data are recorded in Table No. 6.
(C) Antimicrobial activity of 2-isopropoxy-4-substituted phenyl-6-(m-
phenoxy phenyl)-nicotino nitriles (VIa-j).
Antimicrobial activity testing was carried out as described in part-I, sec-
tion-I, page No. 28. The zones of inhibition of test solution are recorded in
Table No. 6a, 6b and 6c.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)





IR  SPECTRAL  STUDY  OF  2-ISOPROPOXY-4-(p-METHYL PHENYL)-6-







































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)





IR  SPECTRAL  STUDY  OF  2-ISOPROPOXY-4-(p-METHOXY PHENYL)-6-












    1510.31-
1589.40

























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)




C-F (str., s, b)
C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-ISOPROPOXY-4-(p-FLUORO PHENYL)-6-












   1510.31-
1604.83




























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)





C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-ISOPROPOXY-4-(p-CHLORO PHENYL)-6-












    1514.17-
1604.83




























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)






C-H (def., v, s)
IR  SPECTRAL  STUDY  OF  2-ISOPROPOXY-4-(p-NITRO PHENYL)-6-












    1512.24-
1572.04





























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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PMR  SPECTRAL  STUDY  OF  2-ISOPROPOXY-4-(p-METHYL PHENYL)-6-
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PMR  SPECTRAL  STUDY  OF  2-ISOPROPOXY-4-(p-METHOXY PHENYL)-6-
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PMR  SPECTRAL  STUDY  OF  2-ISOPROPOXY-4-(p-FLUORO PHENYL)-6-
































































Part-II, Section -III..., “Studies on 2,4,6-trisubstituted-3-cyano pyridines”. 189
PMR  SPECTRAL  STUDY  OF  2-ISOPROPOXY-4-(p-CHLORO PHENYL)-6-
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PMR  SPECTRAL  STUDY  OF  2-ISOPROPOXY-4-(p-NITRO PHENYL)-6-




















































































































































































































































































































































































































































































































































































































































m/z =440.5(M-2), m/z =78(M
+1),
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PART - III
STUDIES  ON CYCLOHEXENONE DERIVATIVES.
INTRODUCTION
Cyclohexenones are derivatives of cyclohexane with carbon joined with
oxygen by double bond known as ketone at position-1 and double bond at
position-2 (I). There are different types of cyclohexenone derivatives, but the
greatest difference in structure and properties is exerted by the groups






Cyclohexenone is the parent of a series of compounds that is important
in agricultural and medicinal chemistry. Cyclohexenones can be conveniently
synthesized by the treatment of α,β-unsaturated carbonyl compounds with
ethylacetoacetate or β-ketoester in basic media.
In recent years cyclohexenone derivatives have gained lot of interest
because of its prominent pharmaceutical properties.
SYNTHETIC ASPECT :
Different methods for the preparation of cyclohexenone derivatives have
been described in literature184-195 as under.
1. By the reaction of substituted diones with methyl vinyl ketone.196
2. By the reaction of 4-alkynals with alkynes in presence of rhodium
catalyst.198
3. By palladium-catalyzed intramolecular oxidative alkylation of various α-
alkenyl- β-diketones and α-alkenyl β-keto esters in the presence of
CuCl2 at room temperature.199
4. By ozonolysis of the corresponding cyclopentenic precursors followed
by intramolecular aldol condensation.200
5. By Bronsted acid-mediated cyclization of siloxyalkynes with simple
arenes.201
Part - III ,   Introduction...,    “Studies on cyclohexenone derivatives”. 210
 6. By the condensation of chalcones with ethylacetoacetate and acetyl
acetone in presence of base through Michael addition.197,202
7. By the microwave irradiation of cyclohexane-1,3-diones on the surface
of silica gel impregnated with indium(III) chloride.203
8. By Yb (OTf)3-promoted palladium-catalyszed oxidative cyclization of
γ-heteroalkenyl-β-keto amides.204
MECHANISM
The addition reaction between ethylacetoacetate and α,β-unsaturated
ketone give cyclohexenone via. Michael addition. This reaction has been
carried out in basic media by using sodium ethoxide or anhydrous K2CO3 in
acetone. During the reaction, nucleophilic addition of carbanion take place to
the C=C of the acceptor. The α,β-unsaturated compound is known as acceptor











































Cyclohexenone and its derivatives are widely used in pharmaceutical
field. Considerable interest has been shown in the chemistry of cyclohexenones













J. Edward et.al.,219 have prepared 2,3-dihydro-5-(3-oxo-2-cyclohexen-
1-yl)-2-benzofuran carboxylic acids (II) and their salts which are used in the










(II)          R3,4,5=H      R2,6 = Substituted phenyl
 S.Toshiyuki et.al.,.220 have prepared some novel cyclohexenone
and screened for their allergy inhibitor, antithrombotic platelet aggregation
inhibitors and fibrinogen antagonist activity. J. Poul et.al.,221 has reported
cyclohexenones possessing cardiovascular, osteoporosis, menpausal
symptoms, estrogen dependent, cancer activities. L. M. Alekseeva  et.al.,222
have synthesized cyclohexenone derivatives which are useful as neurotropic
activity.
  M.A.Salama et.al.,223  have studied antimicrobial activity of
cyclohexenones.  Cyclohexenone possess neutropeptide g-receptor antagonist
activity which was reported by  F.Takehiro et.al.,.224  B.Howard et. al.,225
have demonstrated cyclohexenone as GABA a5 receptor ligands for enhancing
coagulating properties. Cyclohexenones possess inhibitory activity against the
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growth of lettuce seeding found by K. Yasuo et. al.,226
 J. L. Gonzalez de Aguilar et. al.,227  reported neurotrophic activity of
2,4,4-trimethyl-3-(15-hydroxypentadecyl)-2-cyclohexen-1-one in cultured
central nervous system neurons. H. Wikstroem et. al.,228 have synthesized
cyclohexenone ethylamines and ring-condensed analgos as dopaminergic
prodrugs. D. Natalie et. al.,229  have synthesized ethyl 4-[(substituted
phenyl)amino]-6-methyl-2-oxocyclohex-3-ene-1-carboxylates (III) and screened














A. J. Anderson et. al.,231 have synthesized cyclohexenone
derivative (V) and studied on the anticonvulsant activity and potential type IV
phosphodiesterase inhibi tor.  Y.  Takahashi et .al . ,232  have reported







(V) R1,R2=Substituted phenyl (VI)
B.L.Verma et .a l . ,233  have repor ted 3 ,5-d iary l -6-carbethoxy
cyclohexenones (VII). K. R. Scott et.al.,234 have synthesized cyclohexenone
derivative (VIII) and studied on the anticonvulsant activity.

















J. Ruprich et.al.,235 have synthesized cyclohexenone derevatives of
combretastatin-A-4 (IX) and investigated as potential tubulin inhibitors in the
quest for novel anti-cancer agents.  B. Bajia et. al.,236  have synthesized













In l ight of  wide var iet ies of  biological  act iv i t ies exhibi ted by
cyclohexenones  it appeared of interest to synthesize cyclohexenones
derivatives, in order to achieving compounds having better therapeutic activity
described as under.
SECTION-I   : PREPARATION AND BIOLOGICAL EVALUATION OF
METHYL-4-SUBSTITUTED PHENYL-2-OXO-6-(3-
P H E N O X Y P H E N Y L ) - C Y C L O H E X - 3 - E N E - 1 -
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CARBOXYLATES.
SECTION-II   : PREPARATION AND BIOLOGICAL EVALUATION OF
ETHYL-4 -SUBSTITUTED PHENYL-2 -OXO-6 - (3 -
P H E N O X Y P H E N Y L ) - C Y C L O H E X - 3 - E N E - 1 -
CARBOXYLATES.
SECTION-III   : PREPARATION AND BIOLOGICAL EVALUATION OF
6 - A C E T Y L - 3 - S U B S T I T U T E D  P H E N Y L - 5 - ( 3 -
PHENOXY PHENYL)-CYCLOHEX-2-ENE-1-ONES.
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SECTION - I
PREPARATION AND BIOLOGICAL SCREENING OF METHYL-4-
SUBSTITUTEDPHENYL-2-OXO-6-(m-PHENOXYPHENYL)-CYCLOHEX-3-
ENE-1-CARBOXYLATES.
Due to various biodynamic activities205-218 of cyclohexenones and
with a view to have potent therapeutic agents, the synthesis of methyl-4-sub-
stituted phenyl-2-oxo-6-(m-phenoxyphenyl)-cyclohex-3-ene-1-carboxy-
lates (VIIa-j) have been undertaken by the condensation of 1-substituted
phenyl-3-(m-phenoxy phenyl)-2-propene-1-ones (Ia-j) with methyl ac-














The constitution of the products (VIIa-j) have been delineated by elemen-
tal analyses, IR, PMR and Mass spectral data.
The products (VIIa-j) were assayed for their in vitro biological assay
like  antibacterial activity towards S. pyogens MTCC-442, S. aureus
MTCC-96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-
443 (Gram negative) bacterial strain and antifungal activity towards A. niger
MTCC-282 and C. albicans MTCC-227 fungii at different concentrations i.e.
0 (control), 5, 25, 50, 100, 250 (μg/ml). The biological activit ies  of  the
synthesized compounds (VIIa-j) were compared with standard drugs viz.
Amoxicillin, Chloramphenicol, Sparfloxacin, Levofloxacin (antibacterial)
and Griseofulvin, Fluconazole (antifungal).
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REACTION SCHEME
(VIIa-j)
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENING OF METHYL-4-
SUBSTITUTEDPHENYL-2-OXO-6-(3-PHENOXYPHENYL)-CYCLOHEX-3-
ENE-1-CARBOXYLATES.
(A) Preparation of 1-(p-methoxy phenyl )-3-(m-phenoxy phenyl)-2-
propen-1-one (Ij).
For preparation, refer Part - I, Section - I, Page No. 28.
(B) Methyl-4-(p-methoxy phenyl)-2-oxo-6-(m-phenoxy phenyl)-
cyclohex-3-ene-1-carboxylate (VIIj).
A mixture of 1-(p-methoxy phenyl)-3-(m-phenoxy phenyl)-2-propen-
1-one (3.30g, 0.01M), methylacetoacetate (1.16 ml, 0.01 M) and potas-
sium carbonate (1.38 g,0.01 M) was taken into dry acetone (30-40 ml) and
then the mixture was stirred at room temperature till the acetone is evapo-
rated off. The contents were then poured into crushed ice and neutrallised
with hydrochloric acid. The product separated was filtered and crystall ised
from ethanol.Yield : 60%, M.P. : 111°C,  (Required :  C: 75.68%; H: 5.61%  for
C27H24O5, Found : C: 75.63%; H: 5.58% ).
TLC solvent system  Rf1   :  Ethyl acetate : Cyclohexane (3.0 : 7.0)  =  0.57,
TLC solvent system  Rf2   :  Acetone          : Benzene         (1.9 : 8.1)   =  0.54
Similarly, other compounds (VIIa-j) were synthesized. The physical
data are recorded in Table No. 7.
(C) Antimicrobial activity of methyl-4-substituted phenyl-2-oxo-6-
(m-phenoxy phenyl)-cyclohex-3-ene-1-carboxylates (VIIa-j).
Antimicrobial activity testing was carried out as described in part-I, sec-
tion-I, page No. 28. The zones of inhibition of test solution are recorded in
Table No. 7a, 7b and 7c.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)
C-O-C (sym. str., s)
C=O (str., s)
C=O (str., s)
C-H (def., v, s)
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)






































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)










































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C(asym.str.,s)









































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
C-O-C (asym.str.,s)












































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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 C18H16O2  C13H12O3
(B.P.),
(VIIh)
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SECTION - II
PREPARATION AND BIOLOGICAL SCREENING OF ETHYL-4-SUBSTI-
TUTED PHENYL-2-OXO-6-(m-PHENOXY PHENYL)-CYCLOHEX-3-ENE-1-
CARBOXYLATES.
Due to various biodynamic activities205-218of cyclohexenones and
with a view to have potent therapeutic agents, the synthesis of ethyl-4-sub-
stituted phenyl-2-oxo-6-(m-phenoxy phenyl)-cyclohex-3-ene-1-carboxy-
lates (VIIIa-j) have been undertaken by the condensation of 1-substituted
phenyl-3-(m-phenoxy phenyl)-2-propen-1-ones (Ia-j) with ethyl acetoac-













The constitution of the products (VIIIa-j) have been delineated by elemen-
tal analyses, IR, PMR and Mass spectral data.
The products (VIIIa-j) were assayed for their in vitro biological assay
like  antibacterial activity towards S. pyogens MTCC-442, S. aureus
MTCC-96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-
443 (Gram negative) bacterial strain and antifungal activity towards A. niger
MTCC-282 and C. albicans MTCC-227 fungii at different concentrations i.e.
: 0 (control), 5, 25, 50, 100, 250 (μg/ml). The biological activit ies  of  the
synthesized compounds (VIIIa-j) were compared with standard drugs
viz. Amoxicillin, Chloramphenicol, Sparfloxacin, Levofloxacin (antibac-
terial) and Griseofulvin, Fluconazole (antifungal).
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REACTION SCHEME
(VIIIa-j)
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENING OF ETHYL-4-SUBSTI-
TUTED PHENYL-2-OXO-6-(m-PHENOXY PHENYL)-CYCLOHEX-3-ENE-1-
CARBOXYLATES.
(A) Preparation of 1-(p-methoxy phenyl )-3-(m-phenoxy phenyl)-2-
propen-1-one (Ij).
For preparation, refer Part- I, Section - I, Page No. 28.
(B) ethyl -4- (p-methoxy phenyl ) -2-oxo-6- (m-phenoxy phenyl ) -
cyclohex-3-ene-1-carboxylate (VI I I j ) .
A mixture of 1-(p-methoxy phenyl)-3-(m-phenoxy phenyl)-2-propen-
1-one (3.30g, 0.01M), ethylacetoacetate (1.3 ml, 0.01 M) and potas-
sium carbonate (1.38 g,0.01 M) was taken into dry acetone (30-40 ml) and
then the mixture was stirred at room temperature till the acetone is evapo-
rated off. The contents were then poured into crushed ice and neutrallised
with hydrochloric acid. The product separated was filtered and crystall ised
from ethanol. Yield : 63%, M.P. : 118°C,   (Required :  C: 76.00%; H: 5.88%
for C28H26O5, Found : C: 75.97%; H: 5.83% ).
TLC solvent system Rf1   :  Ethyl acetate : Cyclohexane (3.2 : 6.8)  =  0.60
TLC solvent system  Rf2   :  Acetone         : Benzene         (1.5 : 8.5)  =  0.61
Similarly, other compounds (VIIIa-j) were synthesized. The physical
data are recorded in Table No. 8.
(C) Antimicrobial activity of ethyl-4-substituted phenyl-2-oxo-6-
(m-phenoxy phenyl)-cyclohex-3-ene-1-carboxylates (VIIIa-j).
Antimicrobial activity testing was carried out as described in part-I, sec-
tion-I, page No. 28. The zones of inhibition of test solution are recorded in
Table No. 8a, 8b and 8c.
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* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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SECTION - III
PREPARATION AND BIOLOGICAL SCREENING OF 6-ACETYL3-SUB-
STITUTED PHENYL-5-(m-PHENOXY PHENYL)-CYLOHEX-2-ENE-1-
ONES.
Due to various biodynamic activities205-218 of cyclohexenones and
with a view to have potent therapeutic agents, the synthesis of 6-acetyl-3-
substituted phenyl-5-(m-phenoxyphenyl)-cyclohex-2-ene-1-ones (IXa-j)
have been undertaken by the condensation of 1-substituted phenyl-3-(m-













 R= Substituted phenyl
The constitution of the products (IXa-j) have been delineated by elemental
analyses, IR, PMR and Mass spectral data.
The products (IXa-j) were assayed for their in vitro biological assay
like  antibacterial activity towards S. pyogens MTCC-442, S. aureus
MTCC-96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-
443 (Gram negative) bacterial strain and antifungal activity towards A. niger
MTCC-282 and C. albicans MTCC-227 fungii at different concentrations i.e.
0 (control), 5, 25, 50, 100, 250 (μg/ml). The biological activit ies  of  the
synthesized compounds (IXa-j) were compared with standard drugs viz.
Amoxicillin, Chloramphenicol, Sparfloxacin, Levofloxacin (antibacterial)
and Griseofulvin, Fluconazole (antifungal).
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REACTION SCHEME
  (IXa-j)
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENING OF 6-ACETYL-3-SUB-
STITUTED PHENYL-5-(m-PHENOXYPHENYL)-CYCLOHEX-2-ENE-1-
ONES.
(A) Preparation of 1-(p-methoxy phenyl )-3-(m-phenoxy phenyl)-2-
propen-1-one (Ij).
For preparation, refer Part - I, Section - I, Page No. 28.
(B) 6-acetyl-3-(p-methoxyphenyl)-5-(m-phenoxyphenyl)-cyclohex-
2-ene-1-one (IXj).
A mixture of 1-(p-methoxy phenyl)-3-(m-phenoxy phenyl)-2-propen-
1-one (3.30g, 0.01M), acetyl acetone (1 ml, 0.01 M) and potassium car-
bonate (1.38 g,0.01 M) was taken into dry acetone (30-40 ml) and then the
mixture was stirred at room temperature till the acetone is evaporated off. The
contents were then poured into crushed ice and neutrallised with hydrochloric
acid. The product separated was filtered and crystall ised from methanol.
Yield : 61%, M.P. : 138°C,   (Required :  C: 78.62%; H: 5.83%  for C27H24O4,
Found : C: 78.58%; H: 5.78% ).
TLC solvent system   Rf1   :  Ethyl acetate : Cyclohexane (3.2 :6.8)  =  0.55,
TLC solvent system   Rf2   :  Acetone          : Benzene         (2.3 :7.7)  =  0.58
Similarly, other compounds (IXa-j) were synthesized. The physical
data are recorded in Table No. 9.
(C) Antimicrobial activity of 6-acetyl-3-substituted phenyl)-5-(m-phe
noxy phenyl)-cyclohex-2-ene-1-ones(IXa-j).
Antimicrobial activity testing was carried out as described in part-I, sec-
tion-I, page No. 28. The zones of inhibition of test solution are recorded in
Table No. 9a, 9b and 9c.
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* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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C-H (def., v, s)




































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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PART - IV
STUDIES ON  1,5-BENZOHETEROAZEPINES.
INTRODUCTION
Benzoheteroazepines are characterised by their possession of  fused
benzene ring with seven membered hetrocyclic ring containing amino group at
five position and nitrogen,sulphur or oxygen at one position with double bond
in between forth carbon and fifth nitrogen atom.
x
N
(I)          X = NH, S, O
1,5-Benzoheteroazepines viz. benzodiazepine, benzothiazepines and
benzoxazepines are very important compounds because of their pharmacologi-
cal properties. some of the popular drugs based on these compounds are
Thiazesim, Diltiazem237 and Clentienzem238etc.
Many pharmacological compositions of benzoheteroazepines have been
patented.239-242
SYNTHETIC ASPECT
The literature survey revealed that the most explored route for the synthe-
sis of 1,5-benzoheteroazepines is the reaction either of o-phenylene diamine
or o-amino thiophenol or o-amino phenol with 1,3-disubstituted-2-propen-1-ones
(chalcone). 1,5-Benzoheteroazepines are also synthesized by cyclocondensation
of the corresponding 2-substitutted anilines with suitable enones or 1,3 or (α,γ)-
dicarbonyl compounds.246,248-250,252
Different methods for  preparation of 1,5-benzoheteroazepines are
reportd in literature as under.
 Methods for the preparation of 1,5-benzodiazepines are as under.
1. By the condensation of o-phenylenediamine with α,β−unsaturated car
bonyl compounds.243,253,259
2. By the condensation of o-phenylenediamine with β-haloketones.244
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3. By the condensation of o-phenylenediamine with ketones in the pres
ence of polyphosphoric  acid, silics gel254, MgO and POCl3.257
 Methods for preparation of 1,5-benzoxazepines.
4. By the condensation of o-aminophenol with α,β−unsaturated carbonyl
compounds.243,258
5. By the condensation of o-aminophenol with α,β−unsaturated carbonyl
compounds in presence of Amberlyst-15 255 and acetic acid under
MW.260
 Methods for preparation of 1,5-benzthiazepines.
6. By the reaction of o-aminothiophenol with α,β−unsaturated ketones.245
7. By the cyclocondensed of 2-[(E)-2-methoxyvinyl]phenol with 2-amino
thiophenol to obtain oxygen bridged 1,5-benzothiazepine derivatives.247
8. By the reaction of α,β−unsaturated ketones with bis(2-nitrophenyl)












































X= NH, S, O
The mechanism includes the attack of lone pair of electron of nitrogen
atom of 2-substituted aniline (b) on keto-enol form of 1,3-disubstituted-2-
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propen-1-ones (a) affords hydrated product (c) which on dehydration yields
intermediate product (d). Intermediate (d), on intramolecular cyclisation yield
dihyro intermediate (e) in the presence of acid. (e) on tautomerises to the
final product (f).
MEDICINAL INTEREST
Considerable research has been undertaken to extend the activity and
reduce toxicity of Benzoheterozepines. The specific biological activities to
Benzoheterozepines have been summurized as under.











  A. Bauer et. al.,277 have synthesized 4-amino-1,5-benzodiazepines
having psychotropic activity.  R. G. Smith et. al.,278 have synthesized pyrazino
benzodiazepines possesing anxiolytic activity.  G.B. De Sarro et. al.,280 have
synthesized 1,5-benzodiazepines (I) derivatives possessing anticonvulsant
activity.  H.F. Miranda et.al.,282 have reported antinociceptive action benzo-
diazepines. H. Yamaji et.al.,283 have prepared benzodiazepines derivatives
(II) as gastrin receptor antagonists.


















A. Farese et. al.,284 synthesized benzodiazepines and evaluated
their biological activities by luciferase transactivation and anti-viral assay. De
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S. Giovambattista et. al.,285 have synthesized 1,4-benzodiazepine derivatives
as anticonvulsant agents. S. E. Ellen 286 have prepared 1,5-benzodiazepines













 K.A. Rao et. al.,293 have synthesized 1,4-benzodiazepines as DNA-
interactive antitumor antibiotics.  L. Wang et. al.,297 have synthesized benzo-
diazepine derivatives as CDK5 inhibitors. R. Kumar et. al.,300 have synthe-
sized 3H-1,5-benzodiazepine derivatives and screened for anthelmintic ac-
tivities.  S. Joseph et. al.,289 have reported benzodiazepines that activates
cardiac slow delayed rectifier K+ currents.
 T. Nagao et.al.,276 have synthesized 1,5-benzothiazepine derivatives
and tested their coronary vasodilating effect.  K.S. Atwal et. al.,279 have syn-
thesized 1,5-benzothiazepines (IV) ,which are calcium channel blockers.V.







X=S, R1=H, R=Substituted phenyl
(IV)
 C. Saturnino et. al.,287 have synthesized 1,5-benzothiazepines and ex-
amined in vitro for their calcium antagonist activity compared to the diltiazem.
S. Koichi et. al.,288 have prepared  benzodiazepines, benzothiazepines and
benzoxazepines compounds (V),(VI) of potentiating retinoid.
















R1-R3R5R6=H; R4=H, OH,NO2, X=NH,O,S
(V)  (VI)
C. Sanchez-Mateo et. al.,295have studiedneuropharmacological activity of
hetero[2,1] benzothiazepines. F. L. Ansari et. al.,296 have synthesized 1,5-
benzothiazepine derivatives and studied their urease and α-glucosidase in-
hibitors properties. N. Rastkari et. al.,301 have synthesized benzothiazepine









L.R.Swettt et. al.,275 have reported antiinflammatory activity of 4,5-
dihydro benzoxazepine derivatives.  D. M. Zisterer et al290 have reported
pyrrolo-1,5-benzoxazepines as a new class of apoptotic agents.
P. B. Bharucha and H.B. Naik291 has prepared 1,4-oxazipine deriva-
tives and studied their antimicrobial activity.  M. Takashi et. al.,292 have syn-
thesized 4,1-benzoxazepine (VII) derivatives with potent squalene synthase
inhibitory activities.










Shalaby and Alyaa A.294 has synthesized pyrrolo-1,5-benzoxazepine-6
derivatives (IX) and reported as microtubule-targeting agent, in both STl-5H-








 H.  Younes Laras et. al.,298 have prepared various substituted 4,5-
dihydro-3H-spiro [1,5]-benzoxazepine-2,4’-piperidine and assayed as the
possible aspartyl protease inhibitors HIV Protease (HIV-1) and B-Secretase
(BACF-1).
B. Basavaraju et al299 have synthesized methylquinolono[3,2-b][1,5] ben-
zodiazepine (X) and methylquinolono[3,2-b][1,5] benzoxazepine (XI) and its
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In light of wide varieties of biological activities exhibited by 1,5-
benzoheterozepines i t  appeared o f  in terest  to  synthes ize 1 ,5-
benzoheterozepines derivatives, in order to achieving compounds having bet-
ter therapeutic activity described as under.
SECTION-I: PREPARATION AND BIOLOGICAL SCREENING OF 4-
SUBSTITUTED PHENYL-2-(m-PHENOXY PHENYL)-
1H-1,5-BENZODIAZEPINES.
SECTION-II: PREPARATION AND BIOLOGICAL SCREENING OF 4-
SUBSTITUTED PHENYL-2-(m-PHENOXYPHENYL)-
2,5-DIHYDRO-1,5-BENZOTHIAZEPINES.
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SECTION - I
PREPARATION AND BIOLOGICAL SCREENING OF 4-SUBSTITUTED
PHENYL-2-(m-PHENOXYPHENYL)-1H-1,5-BENZODIAZEPINES.
Due to various biodynamic activities261-274 of benzodiazepines
and with a view to have potent therapeutic agents, the synthesis of 4-substi-
tuted phenyl-2-(m-phenoxyphenyl)-1H-1,5-benzodiazepines (Xa-j) have
been undertaken by the condensation of 1-substituted phenyl-3-(m-phe-













  R= Substituted phenyl
The constitution of the products (Xa-j) have been delineated by elemen-
tal analyses, IR, PMR and Mass spectral data.
The products (Xa-j) were assayed for their in vitro biological assay
like  antibacterial activity towards S. pyogens MTCC-442, S. aureus
MTCC-96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-
443 (Gram negative) bacterial strain and antifungal activity towards A. niger
MTCC-282 and C. albicans MTCC-227 fungii at different concentrations i.e.
0 (control), 5, 25, 50, 100, 250  (μg/ml). The biological activit ies  of  the
synthesized compounds (Xa-j) were compared with standard drugs viz.
Amoxicillin, Chloramphenicol, Sparfloxacin, Levofloxacin (antibacterial)
and Griseofulvin, Fluconazole (antifungal).
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REACTION SCHEME
(Xa-j)
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENING OF 4-SUBSTITUTED
PHENYL-2-(m-PHENOXYPHENYL)-1H-1,5-BENZODIAZEPINES.
(A) Preparation of 1-(p-methoxy phenyl )-3-(m-phenoxy phenyl)-2-
propen-1-one (Ij).
For preparation, refer Part - I, Section - I, Page No. 28.
(B) Preparation of 4-(p-methoxy phenyl)-2-(m-phenoxyphenyl)-1-H-
1,5-benzodiazepine(Xj).
A mixture of 1-(p-methoxy phenyl)-3-(m-phenoxy phenyl)-2-propen-
1-one (3.30g, 0.01M), and o-phenylenediamine (1.08 g, 0.01 M) in ethanol
(20ml) and glacial acetic acid  was refluxed for 8 to10 hrs.  The resulting mix-
ture was poured on to crush ice . The  product  obtained was filtered and
crystallized from methanol. Yield : 60%, M.P. : 176°C,   (Required :  C: 83.56%;
H: 5.51%  for C28H22N2O2, Found : C: 83.52%; H: 5.48% )
TLC solvent system  Rf1   : Ethyl acetate : Cyclohexane (3.0 :7.0)  =  0.51
TLC solvent system  Rf2   : Acetone          : Benzene         (2.1 :7.9)  =  0.54
Similarly, other compounds (Xa-j) were synthesized. The physical
data are recorded in Table No. 10.
(C) Antimicrobial activity of 4-substituted phenyl-2-(m-phenoxy-
phenyl)-1-H-1,5-benzodiazepines (Xa-j).
Antimicrobial activity testing was carried out as described in part-I, sec-
tion-I, page No. 28. The zones of inhibition of test solution are recorded in
Table No. 10a, 10b and 10c.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)


























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.

















Part-IV,   Section - I...,    “Studies on 1,5-benzodiazepines”. 310


































































































































Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)











































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)







































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)







































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
Ph-O-Ph (sym. str., s)









































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.























































































































































































































































































































































































































































































m/z =288(M+1), m/z =150,































































































































































































































































m/z =78(M+1), m/z =108(M+1),







 C6H6  C7H8O
C21H15FN2O
 C7H8 C15H12N2( B.P.),
(Xc)

















































































































m/z =362.5, m/z =374.5(M-2),
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SECTION - II
PREPARATION AND BIOLOGICAL SCREENING OF 4-SUBSTITUTED
P H E N Y L - 2 - ( m - P H E N O X Y P H E N Y L ) - 2 , 5 - D I H Y D R O - 1 , 5 - B E N Z O -
THIAZEPINES.
Due to various biodynamic activities261-274of benzothiazepines
and with a view to have potent therapeutic agents, the synthesis of 4-substi-
tuted phenyl-2-(m-phenoxyphenyl)-2,5-dihydro-1,5-benzothiazepines
(XIa-j) have been undertaken by the condensation of 1-substituted phenyl-














The constitution of the products (XIa-j) have been delineated by
elemental analyses, IR, PMR and Mass spectral data.
The products (XIa-j) were assayed for their in vitro biological assay like
antibacterial activity towards S. pyogens MTCC-442, S. aureus MTCC-96
and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-443 (Gram
negative) bacterial strain and antifungal activity towards A. niger  MTCC-
282 and C. albicans MTCC-227 fungii at different concentrations i.e. 0 (con-
trol), 5, 25, 50, 100, 250 (μg/ml). The biological activities of the synthesized
compounds (XIa-j) were compared with standard drugs viz. Amoxicillin,
Chloramphenicol, Sparfloxacin, Levofloxacin (antibacterial) and Griseof-
ulvin, Fluconazole (antifungal).
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REACTION SCHEME
      (XIa-j)
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENING OF 4-SUBSTITUTED
P H E N Y L - 2 - ( m - P H E N O X Y P H E N Y L ) - 2 , 5 - D I H Y D R O - 1 , 5 -
BENZOTHIAZEPINES.
(A) Preparation of 1-(p-methoxy phenyl )-3-(m-phenoxy phenyl)-2-
propen-1-one (Ij).
For preparation, refer Part - I, Section - I, Page No. 28.
(B) Preparation of 4-(p-methoxy phenyl)-2-(m-phenoxyphenyl)-
2,5-dihydro-1,5-benzothiazepine(XIj).
A mixture of 1-(p-methoxy phenyl)-3-(m-phenoxy phenyl)-2-propen-
1-one (3.30g, 0.01M), and o-amino thiophenol (1.25 ml, 0.01 M) in ethanol
(20ml) and glacial acetic acid was refluxed for 8-10 hrs.  The resulting mixture
was poured on crushed ice . The  product  obtained was filtered and crystal-
lized from methanol. Yield : 64%, M.P. : 159°C,  (Required :  C: 80.16%; H:
5.05%  for C28H21NO2S, Found : C: 80.11%; H: 5.00% ).
TLC solvent system Rf1   :  Ethyl acetate : Cyclohexane(3.3 :6.7)    =  0.48
TLC solvent system Rf2   :  Acetone          : Benzene        (2.4 :7.6)    =  0.50
Similarly, other compounds (XIa-j) were synthesized. The physical
data are recorded in Table No.11.
(C) Antimicrobial activity of 4-substituted phenyl-2-(m- phenoxy
phenyl)-2,5-dihydro-1,5-benzothiazepines (XIa-j).
Antimicrobial activity testing was carried out as described in part-I, sec-
tion-I, page No. 28. The zones of inhibition of test solution are recorded in
Table No. 11a,11b and 11c.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)
























 * Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)





































IR  SPECTRAL  STUDY  OF  4-(p-METHOXY PHENYL)-2-(m-PHENOXY-
PHENYL)-2,5-DIHYDRO-1,5-BENZOTHIAZEPINE (XIj).
 * Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)


































IR  SPECTRAL  STUDY  OF  4-(p-FLUORO PHENYL)-2-(m-PHENOXY-
PHENYL)-2,5-DIHYDRO-1,5-BENZOTHIAZEPINE (XIc).
 * Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)


































IR  SPECTRAL  STUDY  OF  4-(p-CHLORO PHENYL)-2-(m-PHENOXY-
PHENYL)-2,5-DIHYDRO-1,5-BENZOTHIAZEPINE (XIb).
 * Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)




































IR  SPECTRAL  STUDY  OF  4-(p-NITRO PHENYL)-2-(m-PHENOXY-
PHENYL)-2,5-DIHYDRO-1,5-BENZOTHIAZEPINE (XIh).
 * Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
























































































PMR  SPECTRAL  STUDY  OF  4-(p-METHYL PHENYL)-2-(m-PHENOXY-
PHENYL)-2,5-DIHYDRO-1,5-BENZOTHIAZEPINE (XIi).




































































PMR SPECTRAL  STUDY  OF  4-(p-METHOXY PHENYL)-2-(m-PHENOXY-
PHENYL)-2,5-DIHYDRO-1,5-BENZOTHIAZEPINE (XIj).

























































PMR SPECTRAL  STUDY  OF  4-(p-FLUORO PHENYL)-2-(m-PHENOXY-
PHENYL)-2,5-DIHYDRO-1,5-BENZOTHIAZEPINE (XIc).
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PMR SPECTRAL  STUDY  OF  4-(p-CHLORO PHENYL)-2-(m-PHENOXY-
PHENYL)-2,5-DIHYDRO-1,5-BENZOTHIAZEPINE (XIb).






























































PMR SPECTRAL  STUDY  OF  4-(p-NITRO PHENYL)-2-(m-PHENOXY-
PHENYL)-2,5-DIHYDRO-1,5-BENZOTHIAZEPINE (XIh).



























































































































































































































































m/z =437, m/z =78(M+1),
m/z =134(M-1),































































































































































































































































































































































































































 C21H15NOS  C22H17NOS
( B.P.),
(XIh)
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SECTION - III
PREPARATION AND BIOLOGICAL SCREENING OF 4-SUBSTITUTED
P H E N Y L - 2 - ( m - P H E N O X Y P H E N Y L ) - 2 , 5 - D I H Y D R O - 1 , 5 -
BENZOXAZEPINES.
Due to various biodynamic activities261-274 of benzoxazepines and
with a view to have potent therapeutic agents, the synthesis of 4-substituted
phenyl-2-(m-phenoxyphenyl)-2,5-dihydro-1,5-benzoxazepines (XIIa-j)
have been undertaken by the condensation of 1-substituted phenyl-3-(m-














The constitution of the products (XIIa-j) have been delineated by elemen-
tal analyses, IR, PMR and Mass spectral data.
The products (XIIa-j) were assayed for their in vitro biological assay
like  antibacterial activity towards S. pyogens MTCC-442, S. aureus MTCC-
96 and B. subtillis MTCC-441 (Gram positive) and E. coli MTCC-443 (Gram
negative) bacterial strain and antifungal activity towards A. niger  MTCC-
282 and C. albicans MTCC-227 fungii at different concentrations i.e. 0 (con-
trol), 5, 25, 50, 100, 250 (μg/ml). The biological activities of the synthesized
compounds  (XIIa-j) were compared with standard drugs viz. Amoxicillin,
Chloramphenicol, Sparfloxacin, Levofloxacin (antibacterial) and Griseof-
ulvin, Fluconazole (antifungal).
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REACTION SCHEME
 (XIIa-j)
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EXPERIMENTAL
PREPARATION AND BIOLOGICAL SCREENING OF 4-SUBSTITUTED
P H E N Y L - 2 - ( m - P H E N O X Y P H E N Y L ) - 2 , 5 - D I H Y D R O - 1 , 5 -
BENZOXAZEPINES.
(A) Preparation of 1-(p-methoxy phenyl )-3-(m-phenoxy phenyl)-2-
propen-1-one (Ij).
For preparation, refer Part-I, Section-I, Page No. 28.
(B) Preparation of 4-(p-methoxy phenyl)-2-(m-phenoxyphenyl)-
2,5-dihydro-1,5-benzoxazepine(XIIj).
A mixture of 1-(p-methoxy phenyl)-3-(m-phenoxy phenyl)-2-propen-
1-one (3.30g, 0.01M), and o-amino phenol (1.09 ml, 0.01 M) in ethanol
(20ml) and glacial acetic acid  was refluxed for 8-10 hrs.  The resulting mix-
ture was poured on crushed ice . The  product  obtained was filtered and crys-
tallized from methanol. Yield : 65%, M.P. : 179°C,  (Required :  C: 83.35%; H:
5.25%  for C28H21NO3, Found : C: 83.30%; H: 5.19% ).
TLC solvent system    Rf1   :  Ethyl acetate : Cyclohexane (3.1:6.9)   =  0.49
TLC solvent system    Rf2   :  Acetone          : Benzene         (1.9 :8.1)  =  0.51
Similarly, other compounds (XIIa-j) were synthesized. The physical
data are recorded in Table No. 12.
(C) Antimicrobial activity of 4-substituted phenyl-2-(m- phenoxy-
phenyl)-2,5-dihydro-1,5-benzoxazepines (XIIa-j).
Antimicrobial activity testing was carried out as described in part-I, sec-
tion-I, page No. 28. The zones of inhibition of test solution are recorded in
Table No. 12a, 12b and 12c.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)


























* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (asym. str., m s)
C-H (sym. str., m)
C-H (asym. def., m)
C-H (sym. def., m)
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)











































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)





C-F (str., s, b)

































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)





C-Cl (str., s, b)
































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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Type  Vibration  mode
C-H (str., v)
C=C & C-C (str., v)
C-H (i.p. def., m)
C-H (o.o.p. def., m)
Ph-O-Ph (asym.str.,s)









































* Abbreviations : s = strong, m = medium, w = weak, v = variable, b = broad, sh = sharp.
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